►
From YouTube: Community Vaccine Advisory Committee Meeting #3
Description
No description was provided for this meeting.
If this is YOUR meeting, an easy way to fix this is to add a description to your video, wherever mtngs.io found it (probably YouTube).
B
Fantastic
sure,
yes,
thanks
bobby,
so
I
want
to
welcome
everyone
to
the
community
vaccine
advisory
committee
meeting
and
I'm
very
excited
to
see
everyone's
faces
again
very
grateful
to
everyone
for
joining
us
today
and
grateful
for
the
really
engaged
participation
that
we've
had
in
the
input
process.
B
I'd
love
to
start
by
you
know
reminding
folks
the
the
core
values
that
are
grounding.
This
effort,
which
is
really
safety,
equity
and
transparency,
are
really
the
core
values
that
we
are
holding
to
guide
our
community
vaccine
input
process
and
I'd
like
to
start
by
also
welcoming
my
my
co-chair
erica
pond
is
is
erica
on.
B
And
so
I
I'd
love
to
start
by
erica.
If
you
want
to
say
a
few
words
and
then
I'll
comment
on
the
agenda
for
today,.
C
Sure
yeah
welcome
everyone,
just
wanna
echo
and
appreciate
all
of
you
taking
your
valuable
time
to
help
advise
us
here
at
the
state.
Your
participation
and
input
and
feedback
is
just
crucial
to
our
effective
response.
I
thought
I
would
just
start
and
just
give
you
all
kind
of
a
state
of
the
state
related
to
covid,
because
it's
of
course
incredibly
relevant
right
now.
C
We
are
seeing
record
high
numbers
of
cases
we
hit
over
30
000
again
today
and
we
have
probably
another
you
know
around
20,
000
or
so
positive
tests
that
we're
trying
to
move
through
the
processing.
But
again
we
are
just
really
on
a
trajectory
that
has
been
very
concerning
and
our
hospitals
specifically
are
are
really
getting
more
and
more
overwhelmed
and,
most
importantly,
the
healthcare
workers.
C
Again,
I
think
we're
getting
more
and
more
staffing
requests,
more
and
more
requests
for
staffing
waivers,
meaning
changing
the
ratio
of
the
numbers
of
healthcare
workers
for
patients
per
healthcare
worker
and
trying
to
get
resources
from
you
know
not
only
around
the
state
but
around
the
country
and
even
internationally,
but
just
super
concerned
that
we're
already
stretched
now.
And
we
know
that
this
record
number
of
cases
we're
seeing
now
will
be
peaking
in
the
hospitals
in
two
or
three
weeks.
C
So
our
and
then
many
of
you
again
have
heard-
and
some
of
these
things
just
bear
repeating,
because
I
know
there's
a
little
bit
of
a
lot
of
questions
or
confusion,
sometimes
around
various
interventions.
But
we
we
launched
this
regional
stay-at-home
order
last
week
and
then,
as
I'm
sure,
you
know
and
have
heard
we
have
had
the
southern
california
region
and
the
central
valley
or
san
joaquin
valley
region.
We're
the
first
regions
to
go
under
this
regional
stay-at-home
order
based
on
an
intensive
care
unit,
capacity
of
less
than
15
percent.
C
So
again,
we're
kind
of
trying
to
project
and
knowing
that
the
other
great
analogy
that
dr
gali
has
been
using
around
this
is
if
we
think
that
all
the
patients
and
cases
are
are
filling
a
tub
and
in
the
tub
is
where
you
have
your
hospital
capacity,
and
we
know
that
there's
a
very
long
pipe
leading
into
that
tub,
and
then
we
need
to
the
hospitals
need
to
work
as
well
with
how
they
can
drain
the
tub
as
far
as
when
they're
doing
discharges
or
if
there
are
any
things
that
they
think
they
can
do
to
either
increase
the
size
of
the
tub
or
or
or
let
the
discharges
out
or
or
other
elective
sort
of,
for
example,
hospitalization.
C
They
are
14.3
today,
so
effective
tomorrow
night
at
midnight.
The
greater
sacramento
area
will
also
be
under
this
regional,
stay-at-home
order
and
essentially
our
message,
and
we
would
love
for
all
of
you
to
help
us.
You
know
disseminate
this
message
as
well
and
we'll
make
sure
we
get
you
a
toolkit
that
our
communications
people
have
around
this
regional
stay
at
home
and
what
it
means,
but
the
bottom
line
is
we
really
want
people
to
stay
at
home,
except
for
any
essential
needs
or
activities.
So,
of
course
you
all
need
to
eat.
C
You
need
to
take
care
of
yourselves
and
your
loved
ones,
and
it's
also
really
important
to
be
able
to
get
some
fresh
air
and
be
outdoors
and
get
exercise.
That's
of
course,
really
important,
but
really
trying
to
avoid
anyone
outside
your
household
unless
it's
essential
and
we've
tried
a
lot
of
other
things.
I
know
there's
a
lot
of
questions
about
this
again
and
in
the
what
we
call
that
purple
tear
and
widespread.
We
had
really
restricted
almost
everything
to
outdoors,
only
and
still
saw
these
skyrocketing
cases
and
now
the
hospitalization.
C
So
we
are
doing
this
next
extreme
to
see
what
we
can
do
to
again
flatten
this
curve
and
and
all
of
your
work
and
the
vaccines
are
the
light
at
the
end
of
the
tunnel
again.
So
it's
really
exciting
that
we
can,
you
know,
see
as
soon
as
next
week
some
delivery
in
the
state
of
vaccines,
but
we
need
our
community
and
our
state
to
hunker
down
for
just
a
few
more
weeks.
C
It's
really
hard
for
all
of
us
and
we
totally
get
that
and
it's
terrible
timing
during
the
holidays
when
we
really
want
to
be
physically
with
our
loved
ones,
but
we
really
encourage
everyone
to
do
that
virtually
for
anyone
outside
your
household.
So
if
you
all,
you
know,
have
questions
about
that.
Please
do
let
us
know,
because
we
again
really
appreciate
your
partnership
and
helping
us
get
out
these
messages,
so
that's
kind
of
the
overall
about
the
surge.
C
I
think
that's
kind
of
the
biggest
updates
as
far
as
the
overall
state
and
again
really
thank
you
all
for
your
time
and
expertise
and
energy
around
this.
We
really
appreciate
your
partnership
and
the
last
thing
is
I'll
be
on
for
the
first
hour,
but
we'll
need
to
jump
off
to
do
a
call
with
our
local
health
departments
to
do
other
updates,
but
again
really
appreciate
all
of
you.
Thank
you.
B
Thank
you
so
much
dr
pond,
and
I
really
want
to
echo
that
urgent
need
for
all
of
us
to
to
come
together
in
this
moment
and
highlight
that
there
is
a
light
at
the
end
of
the
tunnel.
That's
why
we're
all
here
on
this
community
vaccine
advisory
committee,
but
at
the
time
of
this
surge,
really
really
encouraging.
B
All
of
us
to
be
strong
messengers
to
encourage
folks
to
limit
non-essential
activities
stay
home.
You
know
and
do
those
three
w's
that
we
know
wash
hands,
wear,
masks
and
watch
our
distance.
So
for
today's
meeting
we
are
going
to
have
a
conversation
about
the
timing
of
the
vaccine
approval
so
we'll
get
an
update
on
the
on
the
timing
of
the
vaccine
approval.
B
We
are
going
to
have
a
conversation
about
the
definition
of
equity.
We
talked
a
bit
about
that
at
our
last
meeting
and
there
was
another
definition.
B
We
came
back
to
you
all
with
a
definition
of
equity
that
really
reflected
some
of
the
the
themes
and
the
care-abouts
that
we
heard
from
this
committee
and
we'll
also
hear
about
the
the
plan
for
distribution
and
logistics
and
we
and
then.
Finally,
we
will
discuss
the
phase
one
b
criteria
related
to
essential
workers,
so
lots
of
meaty
stuff
to
dive
into
this
evening
this
afternoon,
and
so
I
will
turn
it
over
to
bobby
lunch
to
talk
a
little
bit
about
logistics.
A
Thanks
dr
burke
harris
and
dr
pond,
I
just
wanted
to
review
our
meeting
process
with
a
few
new
additions
today
again,
if
everyone
could
keep
their
cameras
on
so
that
we
can
pretend
we're
all
together
somewhere
and
see
each
other
and
your
microphones
on
mute
until
you're
ready
to
speak
when
you're
ready
to
make
a
comment,
if
you
could
use
the
hand
raise
icon
which
by
now,
I
think
you
all
know
is
located
in
the
participant
section
of
your
zoom
screen
down
at
the
bottom
and
if
you
open
the
participant
list,
you'll
find
a
hand
raise
icon
at
the
bottom.
A
We
really
appreciate
the
incredible
attendance
of
this
group
at
our
last
meeting
last
monday.
We
had
all
but
four
members
attending
and
it
looks
like
we've
got
that
level
of
attendance
again.
I
think
that
really
signifies
your
commitment
to
working
with
this
group
and,
of
course,
the
incredible
importance
of
the
work
that
we're
all
doing
together
today.
We're
very
pleased-
and
we
will,
from
now
on
have
at
our
meetings,
asl
interpretation,
I'd
like
to
welcome
our
two
interpreters,
katie
sales
and
vicki
kennedy.
A
A
A
I'd
like
to
encourage
the
public
to
make
public
comment
in
writing
through
the
covid19
vaccine
outreach
at
cdph.
A
A
The
public
comments
in
total
will
be
sent
out
to
the
members
of
the
committee
in
advance
of
the
meeting
for
their
review,
and
then
I
will
review
the
public
comments
so
that
the
members
of
the
committee
can
consider
those
public
comments
as
we
work
through
our
agenda
and
if
any
of
the
members
have
technical
issues
while
we're
on
the
zoom,
if
you
can
write
them
into
the
chat,
aaron
matlin
who's,
our
I.t
expert
will
see
if
he
can
help
you
with
your
zoom
issues.
B
Thank
you
bobby,
and
so
why
don't
we
go
ahead
and
get
started?
We've
got
lots
to
cover
so
bobby.
Do
you
want
to
start
by
summarizing
the
public
comments?
Yes,.
A
I'd
love
to
thank
you.
Why
don't
we
go
to
the
next
slide,
so
this
is
the
process
that
we're
using
for
summarizing
the
public
comments.
First
of
all,
the
public
comments
that
are
were
sent
out
to
the
members
are
public
comments
that
were
collected
from
november
29th
through
december
7
at
10
pm.
That
was
monday
night.
A
We
had
55
public
comments
submitted
to
the
email
line
and
I'm
going
to
summarize
those
now
all
of
the
members
of
the
community
vaccine
advisory
committee
received
these
comments
in
full
on
tuesday,
so
that
they
could
review
your
public
comments
and
we
close
off
the
timing
before
the
meeting.
So
we
have
time
to
put
the
comments
together
and
so
that
the
members
have
time
to
review
them
in
advance.
A
A
A
We
also
had
comments
on
groups
that
wanted
access
to
the
vaccine
first
or
very
early
from
people
with
intellectual
and
developmental
disabilities,
their
facilities
and
their
staff.
The
metal
can
industry,
rn
case
managers,
the
california,
dental
association,
child
care
workers,
the
critical
infrastructure
representing
gas,
electrical
and
water
industry,
the
medical
device
industry,
laboratory
workers,
public
defenders
and
their
clients,
the
death
care
industry,
blood,
centers,
assistive
technology
providers,
the
news
media
farm
workers
and
people
in
residential
treatment
centers.
A
Another
two
comments
asked
for
additional
data
on
race
and
ethnicity,
characteristics
of
all
the
groups
that
we're
talking
about,
including
calling
out
specific
data
on
native
hawaiians
and
pacific
islanders
and
updating
the
farmworker
data
that
was
presented
at
the
last
meeting
that
will
be
covered
today.
A
In
our
meeting
another
set
of
comments,
the
last
set
of
comments
were
seven
comments,
requesting
participation
as
members
of
this
community
advisory
committee
from
the
airline
pilots
from
health
center
partners,
a
pacific
islander
representative,
a
representative
from
san
bernardino,
county,
a
california
life
sciences,
association
representative,
a
representative
from
the
adult
day,
health
centers
and
a
representative
of
people
with
intellectual
and
developmental
disabilities.
A
E
Thank
you,
dr
burkhares.
Can
you
hear
me
okay,
yeah
coming
through.
Thank
you
good
afternoon.
Everybody
glad
to
be
able
to
talk
to
you
for
a
few
minutes
regarding
this
fast-moving
timeline
of
vaccine
next
slide.
Please.
E
So,
as
the
headlines
are
are
saying
as
well,
the
data
that
has
been
submitted
both
by
pfizer
and
moderna
about
their
candidate
vaccines,
has
been
under
review.
Some
of
it
has
been
is
out
in
the
public
domain
under
on
the
fda
website
and
tomorrow
for
several
hours.
Members
of
the
vaccines
and
related
biologic
projects,
advisory
group,
advisory
committee,
otherwise
known
as
verb
pack,
is
meeting
tomorrow
to
make
a
recommendation
decision
yes
or
no
on
fda,
authorizing
the
pfizer
candidate
vaccine.
E
After
the
thursday
meeting,
the
cdc
and
health
and
human
services
advisory
committee
on
immunization
practices
or
acip
will
be
convening
on
friday
to
review
the
data
as
well
and
on
sunday
as
well
in
the
meantime,
should
birdback
recommend
approval,
then
the
fda
leadership
will
be
considering
an
authorization
decision
over
the
weekend
as
well,
and
so
there's
this
closely
timed
sequence
of
federal
of
first
federal
groups
advising
and
then
recommending
potentially
recommending
and
then
deciding
about
the
vaccine
and
then
standing
in
the
wings
is
the
western
states.
Scientific
safety
review.
E
Work
group
for
membership
from
california,
nevada,
oregon
and
washington,
which
is
poised
to
convene
we'll
be,
is
looking
at
the
data.
The
available
data
now
as
well
and
we'll
be
looking
at
it
over
the
next
few
days
and
be
ready
to
make
a
thorough
but
prompt
evaluation
of
the
process
and
the
information.
E
E
E
As
mentioned,
some
of
the
information
has
already
been
that
has
already
been
posted
on
the
fda
website.
These
are
a
few
slides
regarding
it.
This
slide
shows
some
of
the
the
overall
efficacy
data
from
the
pfizer
candidate
vaccine
at
around
95
vaccine
efficacy,
including
data
in
persons
55
years
and
older
next
slide.
Please.
E
The
data
is
very
detailed
going
into
the
efficacy,
the
number
of
cases
in
the
vaccine
recipients
and
the
placebo
recipients,
various
age
groups,
including
those
75
years
and
older,
in
various
racial
and
ethnic
groups
and
and
in
various
health
and
disease
categories,
those
with
various
types
of
comorbidities
or
other
medical
conditions.
E
Likewise,
the
the
meetings
of
the
advisory
committee
on
immunization
practices
are
public
meetings
and
will
be
available
in
a
number
of
media,
including
including
youtube
accessible
with
links
accessible
on
the
acip
website
for
the
friday
meeting
and
the
sunday
meeting
regarding
this
issue
next
slide.
E
So
this
calendar,
which
I'll
also
talk
about
again
in
a
few
minutes,
sort
of
lays
out
the
timeline
over
the
next
days,
fca
advisory
committee,
thursday
acip
friday
sunday,
and
if
all
of
these
all
of
these
groups
say.
Yes,
we
believe
that
the
information
shows
that
the
vaccine
is
sufficiently
safe
and
effective.
E
Then
next
week,
california
and
the
rest
of
the
country
will
be
receiving
doses
of
the
pfizer
vaccine
for
for
use
into
next
week.
E
As
you
see,
there's
blue
bars
on
this
calendar
as
well,
and
that
refers
to
the
second
candidate
from
a
company
called
moderna
and
a
very
similar
timetable,
one
week
later
regulatory
meetings
and
then,
if
all
looks
well
vaccine
vaccine
becoming
available
the
week
going
into
the
holiday
the
holiday
weekend.
Next
slide.
A
Dr
burkharis,
we
have
time
here
for
some
questions
if
you'd
like
to
take
them
from
the
group.
A
Let's
start
with
rosalind
and
then
we'll
go
to
dr
wasserman,
we'll
start
there
go
ahead
rosalind
and
please
introduce
yourself
with
the
name
of
your
organization.
F
So
I'm
curious,
where
acip
got
this
guidance
from
and
also
I
want
to
emphasize
that
many
of
our
nurses
have
been
denied
testing,
despite
known
exposure
to
a
suspected
or
confirmed
coven
19
case
or
patient
since
the
very
beginning
of
the
pandemic,
and
some
of
our
nurse
leaders
have
spoken
up
about
this,
either
in
the
media
or
with
and
also
with
president-elect
biden
recently,
so
without
adequate
testing
and
contact
tracing.
E
My
my
take
on
the
recommendation
and
I
think,
there's
additional
language
with
that
recommendation.
That
testing
may
not
be
done
ahead
of
time
or
as
a
screening
step
prior
to
receipt
or
prior
to
being
offered
vaccine,
and
I
think
the
consideration
here
is
is
mostly
one
of
scarce
vaccine
and
that,
if,
if
somebody
knew
that
they
had
confirmed
disease
over
the
last
few
months,
they
could
choose
to
defer
temporarily
to
receive
vaccine
and
I
think
the
basis.
E
Your
first
part
of
the
question
the
basis
for
this
recommendation,
or
this
consideration
is
the
looking
at
the
information
so
far
about
when
about
proven
re-infection
for
those
that
are
known
to
have
gotten
a
second
infection
again,
how
how
soon
after
the
first
infection
did
that
occur.
So
this
is
current
expert
information
based
on
what's
been
learned
over
the
last
months
and
it
I
think
the
the
wording
of
the
the
term
puts
the
control
or
the
power
on
terms
of
the
recipient
rather
than
the
employer
or
the
person
offering
the
vaccine
to
make.
E
That
call
so
that,
if,
if,
if
you
knew
you
had,
if
you
knew
you
had
documented
infection,
then
you
could
consider
deferring
to
to
free
up
a
dose
for
for
someone
who
didn't
know
didn't
know
or
hadn't
tested
positive.
E
A
Thanks
rob
for
that
complete
answer,
we're
going
to
go
next
to
dr
wasserman
and
then
to
tia
orr
and
then
to
danny
dan
and
then
to
lisa
coleman
and
make
sure
please
to
introduce
yourself
and
your
organization.
A
G
You
bobby
mike
wasserman,
I'm
with
the
california
association
of
long-term
care
medicine.
You
know
some
of
what
I'm
going
to
say
is
a
bit
of
a
comment.
G
You
know
I
served
on
the
national
academy
committee
that
made
recommendations
on
the
allocation
and
one
of
the
things
that
continues
to
strike
me
is.
We
learn
new
things
every
day
that
continues
to.
We
have
to
respond
to
and
and
and
fold
into,
the
recommendations
that
are
being
made
on
a
daily
basis
and
I'm
sure
that
the
committees
and
work
groups
are
challenged
by
that
and
what
I'm,
what
I
realized
in
listening
to
this
is.
G
G
It's
next
to
impossible
to
keep
the
virus
out
and,
and
then
you
come
down
with
the
real
tough
question
that
we
all
grapple
with.
Is
the
staff
are
the
ones
who
bring
the
virus
in
so
vaccinating
them
makes
the
most
sense,
but
on
the
other
hand,
the
residents
are
the
ones
who
die
from
it
in
addition
to
the
staff
who
have
the
most
dangerous
job
in
our
country
right
now,
so
not
an
easy
question
to
pose.
I'm
just
curious.
E
Thank
you,
dr
wasserman,
and
certainly
share
your
concern
about
the
vulnerability
of
residents
and
staff
in
those
settings
and
the
the
potential
for
for
that
we're
seeing
seen
over
the
year
and
seeing
right
now
or
for
severe
illness
and
death
and
these
vulnerable
vulnerable
settings.
So
the
what
I
can.
E
What
I
can
say
is
that
the
the
initial
california
prioritizations
mere
national
prioritizations
to
emphasize
those
settings
as
high
priority
high
priority
for
early
scarce
doses
and
that
we're
looking
closely
at
the
the
cdc
pharmacy
partnership
and
its
potential
and
its
and
its
how
its
potential
for
serving
these
settings
and
also,
but
not
also
realizing
that
additional
measures
may
be
needed
to
to
protect
workers
and
residents
in
these
settings
so
share.
E
The
concern
believe
that
our
our
efforts
are
are
trying
to
get
vaccine
to
their
those
settings
soon
and,
and
certainly
welcome
your
comments
and
those
of
others
for
these
populations.
H
H
I
noticed
on
slide
10
that
was
just
presented
some
of
the
symptomatic
adverse
events
that
happen
after
the
vaccine
within
seven
days,
and
I
think
on
last
call
we
mentioned,
and
some
other
groups
mentioned
as
well
the
importance
of
ensuring
we
keep
in
mind
the
worker
protections
that
are
necessary
as
we
roll
out
these
different
the
vaccines
and
the
tears
with
the
various
workers
we're
talking
about
from
you
know,
1a
to
1b
and
all
the
way
across
the
board.
H
We
know
that
we
have
sick
leave
protection,
for
example,
that's
expiring
at
the
end
of
december,
we're
going
to
lose
that
we
did
it
at
the
state
level
in
in
modeling
what
the
federal
government
did
we're
going
to
be
working,
hopefully,
along
with
others,
to
make
sure
that's
expanded,
especially
in
light
of
some
of
the
symptomatic
issues
that
we're
going
to
see
as
this
vaccine
is
dis,
distributed.
Obviously,
ppe
and
workers,
comp
and
other
worker
protections.
H
We
want
to
make
sure
that
we're
mindful
of
and
that
we
keep
intact,
as
this
vaccine
is
rolling
out,
especially
important
as
I
took
a
look
at
slide,
10
and
seeing
some
of
those
adverse
effects.
So
I
just
wanted
to
add
that
in
thank
you
bobby.
I
Hi
thanks
dr
schechter,
danny
chan
from
justice
and
aging
appreciate
your
updates.
I
had.
I
just
want
to
piggyback
off
of
what
dr
wasserman
was
saying
and
hope
that
in
sort
of
the
allocation
of
the
scarce
vaccines
in
the
initial
batch
that
you
all
will
keep
in
mind
that
it
was
last
week
the
california
healthcare
foundation
released
a
report
indicating
you
know
that,
in
particular
in
facilities
where
there
are
more
black
and
latino
residents,
there
are
higher
chances
of
an
outbreak.
I
I
mean,
as
we
think,
about
equity
and
to
sort
of
all
the
conversations
we've
been
having
about
equity.
Really
thinking
about
factoring
that
in
in
how
you
allocate
you
know
or
how
counties
are
allocating
where
those
scarce
vaccines
are
going.
My
question
is
on
the
timeline.
My
understanding
is
that
the
the
a
piece
of
this
is
the
federal
partnership
with
walgreens
and
cvs
to
deliver
the
vaccines
and
vaccinate
in
long-term
care
settings,
and
my
understanding
is
that
that
is
contingent
upon
a
state
activation
that
california
will
activate
at
some
point.
I
E
Thank
you
we're,
I
think,
likely
to
make
an
activation
decision
shortly.
As
for
a
careful
consideration
of
both
the
issues
that
you
and
dr
wasserman
are
bringing
about
the
urgency
of
the
need
and
then
also
the
implications
for
directing
doses
to
that
program
and
the
timing
of
directing
those
doses
to
the
to
the
program
in
that
there's,
once
doses
are
directed
there,
they
may
not
be
available
immediately
for
other
purposes,
so
trying
to
find
that
sweet
spot
to
get
things
as
soon
as
possible
and
balance
and
balance
the
needs.
E
C
And
I
might
just
add
one
quick
thing
that,
although
dr
schechter
or
or
trisha
blocker
correct
me
if
I'm
wrong,
but
I
think
our
other
consideration
is
that
our
understanding
is
those
pharmacists
pharmacies
would
still
be
looking
for
staff
to
provide
the
vaccination
and
and
so
and
they
don't
necessarily
have
those
ready
to
go.
C
And
so
it's
not
like
if
we
activate
they're,
ready
and
back
to
dr
schechter's
point
if
they're
not
ready
to
go
and
we
are
or
the
healthcare
systems
are
ready,
we
want
to
again
make
sure
that
the
vaccine
that
comes
can
be
used
as
quickly
as
possible
and
then
emits
this
healthcare
workers,
staffing
shortage.
You
know
that
we're
already
talking
about
on
multiple
levels,
we're
not
sure
if
everyone's
competing
for
those
same
staff.
So
that's
just
another
layer
of
that
consideration.
A
E
I
appreciate
appreciate
the
concerns
and
the
and
the
numbers
flying
around
so
given
that
acute
care,
given
the
number
of
doses
in
that
327
and
that
that's
being
followed
shortly
in
the
following
weeks,
to
get
up
to
around
2
million
doses
or
so
2
million
plus
by
the
end
of
the
month
and
then
followed
by
more
so
the
the
the
1a,
the
1a
of
healthcare
workers
and
long-term
care
residence
is,
is
broader
than
the
327.
E
The
327
is
the
first
installment
most
of
that,
because
the
because
many
facilities
most
facilities
are
signed
up
for
the
pharmacy
partnership.
Those
facilities
are
mostly
going
to
be
served
outside
of
the
327
and
some
of
the
additional
doses,
and
they
will
be
doses.
California,
doses
directed
to
that
that
partnership
shortly
will
be,
will
be
that
that
piece
of
it
it
may
be
that
in
some
counties
there
will
be
supplemental
efforts
to
reach
facilities
outside
of
the
partnership
as
well.
E
So
a
few
strands
there
a
few
a
few,
a
few
parts
to
it.
But
I
I
think
in
short,
the
327
is
likely
to
end
up
largely
in
with
in
hospital
settings
the
pharmacy
partnership.
Following
close
behind
to
reach
a
large
proportion
of
skilled,
nursing
and
assisted
living
and
related
facilities
around
the
state
and
some
supplemental
local
efforts
to
reach
reach
some
of
those
facilities
as
well,
I
hope
that
I
hope
that
helps.
A
Okay,
pastor
boyd:
it's
good
to
see
you
thanks
for
making
a
comment
and
then
we'll
go
to
deborah
and
then
we'll
see
how
we
are
with
timing
on
this
agenda
item.
K
At
this
point
and
rolling
out,
I
represent
the
african-american
community
empowerment
coalition
council
for
the
state
of
california,
an
advocacy
organization
and
also
pastor
first
city
church
here,
in
los
angeles,
so
understanding
the
perceived
reluctance
of
some
members
of
the
african-american
community
to
participate
in
the
inoculation
program
based
upon
the
tuskegee
project
and
other
related
experiments
that
were
done
on
members
of
the
african-american
community
and
other
communities
of
color
in
past
years.
K
What,
in
your
professional
opinion,
can
we
say?
How
can
we
as
leaders
in
african-american
and
other
communities
of
color,
especially
those
low-income
communities,
address
this
issue
in
this
matter,
with
a
level
of
comfort
and
confidence
with
members
of
this
community,
encouraging
them
to
participate
in
the
process
of
inoculation
or
vaccination
early
on
especially
understanding
that
there
is
a
disproportionate
and
an
inequitable
propensity
of
that
members
of
that
population
to
be
infected
by
the
disease
and
by
the
virus?
K
So
what
is
it
that
we
can
actually
say
to
increase
the
participation
in
our
communities.
A
Dr
burke
harris
would
you
like
to
start
answering
that
and
then
see
if
dr
pon
or
rob
would
like
to
ask.
B
Sure
I'm
happy
to
so.
I
think
one
of
the
things
that
is
important
is
for
us
to
acknowledge
that
terrible
history
and
recognize
that
it
was
wrong
and
it
should
not
have
happened
and
also
acknowledged
that
those
incredibly
damaging
practices
actually
created
the
foundations
for
many
of
the
modern
safeguards
that
we
have
in
biomedical
research
and
in
medical
care.
So
part
of
the
reason
why
there
are
laws
about
informed
consent
was
because
after
the
tuskegee
was
completed,
and
it
didn't
end
until
the
1970s.
B
I
mean
people
really
don't
remember
that
this
was
you
know
this.
This
was
not
that
long
ago
that
it
was
following
the
discovery
that
that
clearly
the
participants
of
the
tuskegee
study,
one
of
the
things
they
identified
was
that
they
were
told
one
thing,
but
really
investigators
were
investigating
something
else
right.
The
the
natural
history
of
untreated
syphilis
was
what
they
were
really
investigating,
and,
and
so
that
is
actually
that
actually
became
the
foundation
for
modern
laws
about
informed
consent.
B
And
so
you
know
not
that
one
of
the
things
that
I
hope
that
the
public
takes
confidence
in
is
when
we
look
at
the
lessons
learned
from
tuskegee.
B
It's
not
just
that
we,
you
know
understood
that
something
terrible
happened,
but
that
we
have
taken
action
to
ensure
that
that
it
can
never
happen
again,
and
we
do
that
through
informed
consent.
We
do
that,
through.
You
know
legal
regulations
to
ensure
that
these
types
of
things
are
prohibited.
B
So
I
think
that
piece
is
really
important
for
us
to
communicate,
but
also
to
recognize
that
here
in
california,
we
have
a
foundational
grounding
in
equity.
Governor
newsom
has
been
clear
about
the
importance
of
california
for
all,
and
I
think
that
that
is
demonstrated
in
the
diversity
of
our
scientific
review
panel.
It's
demonstrated
in
the
diversity
of
this
process.
It's
demonstrated
in
the
openness
of
this
process.
B
We
want
to
have
a
a
process
that
californians
can
trust
in
and
we
are
looking
to
everyone
who
is
part
of
this
committee
to
help
us
build
that
process,
and
that's
why
we
are
you
know,
that's
that's
why
you're
here?
We're
really
grateful
to
have
you
as
part
of
this
process,
so
that
we
can
have
a
process
that
everyone
has.
Confidence
is
truly
grounded
in
safety,
equity
and
transparency.
C
This
is
dr
pawn.
I
would
just
echo
that,
and
I
think,
in
addition,
I
think,
as
far
as
really
specifics
and
and
moving
forward
we're
doing
some
work,
both
with
our
own
communications,
lead
and
partnering,
with
stop
cover
19
with
one
of
our
drafting
guidelines,
work,
group
leaders,
dr
arlene
brown,
on
really
working
on
messaging
and
and
what
what
can
really
help,
and
we
will
absolutely
be
sharing
that
with
all
of
you
both
for
feedback
and
for
for
dissemination
as
well.
So
thank
you
for
bringing
up
that
really
really
important
point
thanks.
E
No,
I
I
I
don't
have
anything.
I
don't
have
anything
to
add
to
the
conversation.
L
E
Hoping
that
between
cdc's
national
efforts
and
state
efforts
and
local
efforts,
there
will
be
lots
of
outreach
and
lots
of
information
to
to
try
and
answer
questions
and
concerns
and
want
to
hear
from
you
when
we're
off
the
mark
or
when
we
need
where
the
gaps
are
and
where
we
can
do
better.
A
So
we
have
time
in
the
session
for
one
more
comment
from
deborah,
shade
and,
and
then
those
of
you
that
are
got
other
questions
you
can
put
them
in
the
chat
or
we'll
catch
it,
as
we
continue
to
talk
about
this
issue
later
in
the
agenda.
M
So
I
just
had
a
quick
comment
about
the
pfizer
data
and
the
adverse
effects.
Will
the
adverse
effects
data
be
broken
down
by
demographics
and
population
because,
what's
reported
in
the
document,
I
don't
see
that
breakdown.
That's
question
number
one
and
I
think
in
terms
of
vaccine
hesitancy,
you
know
the
information
we're
hearing
from
the
press,
the
two
cases
in
in
england
today.
M
If
you
have
it
and
you
know
ensuring
safety
moving
forward,
because
there
will
be
a
large
population
that
that
would
be,
you
know
that
could
prevent
them
from
following
through
on
the
second
dose.
So
just
wanted
to
know
if
you
had
any
information
on
the
demographic
breakdown
of
that
and
were
there
certain
populations
that
were
more
at
risk
for
adverse
side
effects
or
if
they
will
be
presenting
that
tomorrow.
E
A
short
answer
would
be
stay
tuned
for
the
information
that
I
I
think,
there's
limited
detail
in
the
briefing
in
the
briefing
packages,
both
the
pfizer
and
the
fda
and-
and
I
believe
that
will
be
a
topic
tomorrow-
about
further
having
the
subgroups,
whether
whether
by
age
or
race,
or
co-morbidity
or
ethnicity.
E
So,
and
and
couldn't
agree
with
you
more
that
that
the
combination
of
a
vaccine
that
does
have
that
does
have
some
some
moderate
rates
of
sore
arms
and
fatigue
and
and
some
folks
who
will
get
fever
causes
because
of
of
concern
and
that
and
that
coincidental
things
are
going
to
happen
and
and
to
be
able
to
provide
context.
E
Provide
accurate
information
about
what
to
expect
accurate
information
about
the
about
the
safety
and
how
well
the
vaccine
works
and
to
to
be
able
to
anticipate
and
answer.
Questions
on
safety
is
is
really
paramount,
and
I
will
appreciate
your
support
in
in
serving
and
sharing
that
information
as
well
and
again
again
providing
an
accurate
picture
of
the
benefits,
as
well
as
as
well
as
any
as
well
as
any
safety
concerns.
B
Thank
you,
dr
schechter,
and
I
think
we
can
move
forward
with
a
conversation
about
the
definition
of
equity
and,
as
we
know,
I
think
this
was
something
that
was
important
and
that
we
heard
from
our
committee
was
something
that
was
important
and,
as
we
know,
this
process
and
the
work
of
this
committee
is
grounded
in
the
values
of
safety,
equity
and
transparency.
B
And,
as
we
discussed,
the
role
of
this
committee
as
an
advisory
is
to
give
a
input
for
the
drafting
guidelines.
B
Work
group
to
be
considering,
as
they
are
thinking
about
the
the
the
drafting
of
guidelines
and
and
really
to
give
a
voice
to
all
of
the
constituents
that
you
represent
to
give
a
voice
to
the
public
in
this
process
and
make
sure
that
our
drafting
guidelines
work
group
is
considering
all
of
all
of
these
factors
and
when
we
started
this
process
on
in
our
first
meeting,
we
talked
I'm
sorry
in
our
second
meeting
on
the
november
30th
meeting,
we
talked
about
the
definition
of
equity,
as
according
to
the
world
health
organization.
B
Health
equity
quote
implies
that,
ideally,
everyone
should
have
a
fair
opportunity
to
attain
their
full
health
potential
and
that
no
one
should
be
disadvantaged
from
achieving
this
potential
and,
based
on
the
conversations
of
this
group,
we
sought
to
present
an
additional
definition
of
equity,
one
that
was
included
in
the
national
academies
of
sciences
and
engineering
and
medicine
leading
health
indicators,
2030
report
that
highlights
advancing
health,
equity
and
well-being,
and
in
that
definition
they
talked
about
health
equity
as
being
defined
by
the
hhs
office
of
minority
health
as
attainment
of
the
highest
level
of
health
for
all
people,
and
they
recognized
that
achieving
health
equity
requires
valuing
everyone
equally
with
focused
and
ongoing
societal
efforts
to
address
to
address
avoidable
inequities,
historical
and
contemporary
injustices
and
the
elimination
of
health
and
health
care
disparities.
B
And
what
we
wanted
to
do.
We
we,
we
shared
this
definition
at
the
last
meeting,
but
what
we
wanted
to
do
is
offer
an
opportunity
for
discussion
and
also
at
the
at
the
end
of
this
discussion,
to
take
a
poll
and
come
to
agreement
on
which
definition
we
want
to
adopt
and
offer
to
the
drafting
work.
Drafting
guidelines.
Work
group,
as
the
definition
that
we
want
them
to
be
working
with
as
they
are
considering
drafting
their
recommendations,
and
so
I
want
to.
B
A
Great
thank
you,
dr
burkharis,
before
we
take
comments,
two
things
for
any
of
you
that
are
on
your
telephone.
Instead
of
the
zoom
line,
we're
getting
some
feedback
on
the
public
line.
If
you
could
put
your
telephones
on
mute,
we
know
all
of
you
that
are
on
the
zoom
are
on
you.
But
if
you
could
put
your
telephones
on
you,
maybe
we
could
get
rid
of
some
of
the
feedback
on
the
public
line
and,
secondly,
those
of
you
that
had
your
hand
up
in
the
last
session.
A
We
want
comments
now
on
the
equity
definition
and
I'm
going
to
start
with
andy
and
then
those
of
you
that
had
your
hand.
Ups
for
the
previous
conversation,
if
you
want
to
make
a
comment
on
equity,
we
certainly
would
welcome
that.
But
that's
what
we
want
to
hear
comments
on
right
now.
So
andy,
let's
start
with
you,.
N
So
when
I
see
a
definition
of
health
equity
that
talks
about
the
highest
possible
level
of
health,
I
worry
about
who
is
defining
that
and
if
it's
a
physician
that
has
an
inherently
negative
view
of
a
disability
status
from
a
health
outcome
perspective,
they
may
be
discriminating
against
people
with
disabilities,
who
don't
want
the
same
level
of
quote-unquote
health
that
a
health
care
professional
expects
us
to
want
for
ourselves.
So
some
notion
of
well-being,
some
notion
of
access,
equal
access
to
health
feels
better
to
me
than
the
idea
of
the
highest
possible
level
of
health.
A
Thank
you
andy
for
that
thoughtful.
An
important
comment,
I'm
going
to
ask
joe
diaz
joe,
is
your
comment
about
health
equity
and
this
equity
definition.
I
know
your
hand
was
up
earlier.
O
Yeah,
it
was,
and
one
was
already
addressed
by
dr
harris
reference
to
informed
consent,
the
other
and
then
was
covered
in
some
of
the
notes
regarding
individuals
with
intellectual
disabilities.
O
We've
got
over
1400
facilities
like
that
in
california,
besides
long-term
care,
and
that
was
my
only
thought
that
I
wanted
to
make
sure
that
we
took
them
into
consideration,
because
individuals
with
intellectual
disabilities
have
a
real
complex
situation
and
lifestyle,
and
so
forth
and
part
of
the
equity
feature
needs
to
be
the
ability
for
them
to
have
articulated
representatives
that
are
willing
to
take
the
time
to
discuss
the
challenges
and
the
needs,
especially
as
we
go
forward
into
this
deployment
of
of
the
vaccine,
and
these
are
the
probably
one
of
the
most
frail
in
addition
to
our
long-term
care
residents.
A
Great
thank
you,
joe
for
adding
that
comment.
Let's
go
on
to
we'll
go
to
deep
sing
and
then
we'll
go
to
susan
demaro
and
then
to
dr
ton
and
then
we'll
see
how
our
time
is
on
this
discussion.
P
One
thing
I
just
wanted
to
lift
up,
especially
if,
if
we're
looking
at
the
nasim
reports,
definition
where
there's
actually
a
prescriptive
part
of
it
excuse
me,
then
I
would
definitely
suggest
us
also
in
in
our
in
what
we're
talking
about
what
is
required
from
in
the
goal
of
attaining
health
equity,
actually
like
specific
language,
not
not
just
about
avoiding
inequalities,
but
also
talking
about
specific
resource
allocation
to
those
and
and
to
actually
say
that
explicitly
that
there
would
be
a
resource
allocation
component
in
terms
of
what
we're
specifically
trying
to
address.
A
Thank
you,
dude,
okay,
thanks
susan
for
stepping
out
of
the
queue,
dr
tom,
why
don't
we
go
to
you
next
and
then
we'll
go
to
ron
and
kelly.
Q
Hi
henry
tan,
I'm
chief
diversity
officer
at
uc,
davis,
health
and
I
represent
the
california
medical
association.
Q
I
think
that
what
what
I
would
propose
to
also
include
into
this
is
that
recognition
that,
in
order
to
attain
health
equity,
that
that
we
need
to
have
strong
and
trusting
partners
with
communities
and
stakeholders
of
health.
R
Hi,
so
I
I'm
chief
perdiganis,
I'm
from
seiu
local
1000
and
my
view
as
a
nurse
and
a
state
worker
is.
We
cannot
just
address
health
equity
by
defining
it.
We
need
to
also
define
health
iniquity,
which
refers
to
preventable
avoidable,
unfair
and
unjust
differences
resulting
from
poor
governance,
corruption
or
cultural
exclusion,
and
disparity
in
accessibility
to
these
health
care
and
other
services,
so
that
the
disadvantaged
group
has
difficulty
getting
who
has
difficulty
getting
or
accessing
them
than
the
co-existing
social
group.
R
A
You
g
brianna
was
your
question
about
the
equity
definition,
or
was
it
left
over
from
a
previous
conversation?
Okay,
great
we'll
go
on
to
erin
carruthers
thanks
brianna
aaron.
S
Thank
you
bobby,
and
this
is
erin
carruthers
executive
director
of
the
state
council
on
developmental
disabilities,
which
includes
intellectual
disabilities
and
joe
diaz.
I
wanted
to
thank
you
for
raising
the
comments,
because
the
core
of
the
comedy
is
really
about
informed
consent,
and
you
raised
a
particular
barrier
or
difficulty
that
may
have
with
people
with
intellectual
disabilities,
and
how
do
you
raise
informed
consent,
but
the
point
that
you
make
is
really
broader
than
people
with
intellectual
disabilities.
S
Many
of
our
communities
are
going
to
struggle
with
informed
consent
and
informed
consent
is
the
cornerstone
of
informed
consent
is
knowing
that
the
vaccine
is
safe
for
the
person
who's
receiving
it
and
as
we
go
further
into
our
conversations
I'll
be
interested
into.
You
know
what
we're
learning
from
the
medical
advisory
group
and
was
also
why
I
put
comments
into
the
box
to
try
to
understand
and
make
sense
of
the
little
bit
of
medical
information
we
have
here.
Thank
you.
A
Thanks
aaron
for
addressing
that,
so
I'm
going
to
turn
the
conversation
about.
Oh,
go
ahead,
christina!
Why
don't
you
comment
and
then
we'll
go
back
to
dr
burke
harris.
T
Thanks
bobby,
this
is
christina
mills,
the
executive
director
of
the
california
foundation
for
independent
living
centers.
We
represent
disability
rights
organizations
known
as
ilcs
across
the
state,
and
I
just
wanted
to
quickly
add
that,
while
we're
talking
about
folks
with
disabilities-
and
I
really
appreciate
what
andy
imperato
brought
up
in
making
sure
that,
while
we've
already
been
dealing
with
and
assisting
the
state
and
ensuring
that
rationing
of
health
care
is
not
something,
our
state
has
to
do
and
ends
up
discriminating
against
people
with
disabilities.
T
As
a
result,
I
also
want
to
bring
up
the
fact
that,
while
we
can
and
as
early
as
possible,
it
may
not
be
a
part
of
this
specific
conversation,
but
I
want
to
put
it
in
our
head
that
we
need
to
make
vaccines
as
accessible
to
get
to
as
possible.
Our
community
has
had
outstanding
challenges
in
getting
testing
and
getting
information
from
healthcare
providers
and
from
public
health
on
ways
to
get
accessible
testing
and,
unfortunately,
in
some
of
those
cases
not
received
appropriate
testing
or
accessible
testing.
B
Well,
thank
you,
everyone
for
those
that
thoughtful
input,
and
what
we
can
do
is
that
we
will
go
ahead
and
make
sure
that
all
of
that
input
is
communicated
to
the
drafting
guidelines
workgroup
so
that
all
of
that
can
be
considered.
B
So
we're
very
grateful
for
that,
and
I
think
now
it's
worth
taking
the
time
just
to
do
a
quick
poll
to
see
how
whether
or
not
folks
are
would
like
to
adopt
this
definition
of
equity
and-
and
I
think
that,
if
not,
then
we
can
default
back
to
the
definition
that
includes
everyone
should
have
a
fair
opportunity.
B
So
do
you
want
to
bobby?
Should
we
go
ahead
and
put
the
problem.
A
Unfortunately,
we
don't
have
both
definitions
available
today,
but
we
have
this
definition
so.
A
Yeah,
why
don't
you
read
it
again,
dr
burke
harris
and
then
these
people
can
hear
the
second
definition.
B
Great,
so
the
who
definition
is
that
health
equity
implies
that,
ideally,
everyone
should
have
a
fair
opportunity
to
attain
their
full
health
potential
and
that
no
one
should
be
disadvantaged
from
achieving
this
potential
and
then
the
definition
of
equity
from
the
nasam
report
that
was
originated
originally
from
hhs
is
attainment
of
the
highest
level
of
health
for
all
people.
Achieving
health
equity
requires
valuing
everyone
equally
with
focused
and
ongoing
societal
efforts
to
address
avoidable
inequalities,
historical
and
contemporary
injustices
and
the
elimination
of
health
and
health
care
disparities.
A
It
looks
like
a
number
of
you
are
putting
your
revision
ideas
in
the
chat,
which
is
great,
so
if
you
want
to
go
ahead
and
vote
one
way
or
the
other
and
put
your
revisions
in,
that
would
be
great,
we'll
just
take
another
minute
here
and
again,
the
chat
will
be
saved
and
sent
out
to
everyone,
and
we
also
summarize
it
for
the
drafting
guidelines.
Group.
A
A
On
okay,
it
looks
like
we
have
78
members
of
our
group
and
we
have
three
missing
today,
an
unbelievable
attendance
again.
So
it
looks
like
we
have
a
majority
of
the
group
of
two-thirds
of
the
group
in
agreement
with
a
number
of
reservations
which
will
be
recorded.
So
we
will
end
the
poll
and
of
dr
burkharis.
I
think
we're
ready
for
a
break
and
to
move
on.
B
Okay,
well,
thank
you
so
much.
Thank
you.
Everyone
for
your
input,
recommendations
and
suggestions
on
how
to
improve
our
conceptualization
and
definition
of
equity.
That's
very
much
appreciated,
and-
and
now
we
have
a
moment
for
a
break
so
we'll
take
a
10
minute
break
and
we
will
reconvene
at
4
15.
B
L
L
L
B
Wonderful,
thank
you
so
much
bobby
and
I
hope
everyone
had
a
a
wonderful
break
and
I
think
now
we
are
going
to
hear
a
bit
about
the
initial
discussions
of
cdph
for
plans
for
distribution
and
logistics.
B
So
trisha
blocker
from
deputy
director
of
our
office
of
emergency
preparedness
and
the
california
department
of
public
health
and
dr
rob
schechter
chief
of
our
immunizations
branch,
will
go
ahead
and
start
the
initial
conversation
about
planning
for
distribution
and
logistics
of
the
vaccine.
A
E
Thank
you
bobby.
This
is
rob
schrechter
again
and
trisha
tricia
blocker
world,
I
think,
is
on
and
we'll
be
helping
out
along
the
way.
Next
slide,
please,
whenever,
whenever
you're
ready.
E
So
I
think
we've
shown
a
similar
slide,
perhaps
at
the
kickoff
meeting,
but
it
it.
I
think
it's
helpful
to
talk
about
as
a
start.
What
usually
happens
in
california
each
year
and
each
fall
before
the
pandemic
to
get
a
feel
for
the
capacity
of
the
vaccine
that
that
gets
delivered
and
where
does.
E
Each
fall
over
about
three
months
gets
a
dose
of
flu
vaccine
and
that
there
are
tens
of
millions
of
doses
given
in
of
other
routine
vaccines,
given
primarily
in
childhood,
and
most
of
these
are
given
in
clinics
or
hospitals,
increasingly
in
pharmacies,
and
then
public
health
stands
by
as
a
safety
net
provider,
giving
perhaps
fewer
than
10
percent
of
these
doses
in
routine
times
and
doubling
that
capacity
10
years
ago
during
the
h1n1
pandemic
and
is
also
in
charge
of
allocating
most
of
the
local
supplies
of
pandemic
vaccines.
E
So
there
were
earlier
questions
about
all
these
numbers,
about
the
the
doses
of
vaccine
and
initially
for
the
the
first
shipment
of
pfizer
vaccine
is
in
the
ballpark
of
a
third
of
a
million
doses,
and
then
it
if,
in
addition,
if
moderna
vaccines
are
available
as
well,
the
number
of
doses
of
combined
for
the
pfizer
and
moderno
somewhere
the
area
of
two
million
doses
by
the
end
of
the
month.
E
I
believe
the
secretary
of
health
and
human
services
was
quoting
this
morning
about
50
million
nationwide
by
the
end
of
january,
which
would
be
somewhere
in
the
range
of
of
six
million
or
so
doses
coming
by
the
end
of
january.
So
additional
4
million
doses
in
january
next
slide.
Please.
E
Again,
here's
the
calendar
so
that
if
all
of
these
regulatory
steps
proceed
in
order
that
starting
next
week
by
tuesday,
the
15th
or
into
the
end
of
the
week,
those
327
000
doses
of
pfizer
vaccine
would
be
coming
into
the
state
around
to
supplies
going
statewide
to
all
of
our
counties
and
then
should
the
same
process
happen
again
from
adjournevac
scene.
The
following
starting
the
end
of
next
week,
then
both
pfizer
and
modernitos
is
available
in
california.
E
That
week
of
the
21st,
the
the
number
of
moderna
vaccines
I
saw
there
was
a
chat
question
around
this
somewhere
between
600
and
700
000
doses
that
might
be
available
starting
that
week
of
the
the
21st
into
the
end
of
december.
For
the
first
person
of
modern
doses.
E
The
prioritization
guidance
we
discussed
last
week
in
which
health
care
workers
and
residents
of
long-term
care
facilities
are
prioritized
in
a
ranked
order,
and
then
using
that
that
the
number
of
doses
and
the
number
of
providers
allocating
doses
to
two
providers
who
can
serve
these
communities
and
then
passing
those
orders
on
to
the
state
health
department.
Next
slide.
Please.
E
In
which
we
we
trend,
we
pass
those
orders
on
quick
review
and
pass
those
orders
on
to
a
national
national
system
combined
with
cdc
and
the
vaccine
manufacturers.
Next
slide.
E
Those
orders
get
processed
and
then
those
doses
get
delivered
around
the
country
and
that
that
time
frame
is
can
be
as
short
as
a
a
few
days
or
less
between
the
local,
the
local
local
decisions
on
the
orders
and
then
the
doses
arriving
somewhere
in
the
area
of
a
few
to
several
days.
Next
slide.
E
Please
the
when
the
vaccines
get
from
the
the
manufacturer,
sometimes
they're,
coming
directly,
such
as
the
pfizer
vaccine,
because
of
its
cold
temperature
standards
comes
directly
from
the
manufacturer
to
the
clinic
or
hospital
or
other
site,
whereas
the
modern
vaccines
and
many
of
the
others
will
come
through
an
intermediary
distributor.
E
The
temperature
standards
are
maintained
throughout
this
process,
whatever
whatever
the
standards
are
for
the
particular
vaccine,
whether
that's
refrigeration
or
freezing
or
ultra
low,
very
low
temperatures.
Next
slide,
please,
once
the
the
packages
of
the
vaccine
arrive
in
the
the
back
door
or
the
loading
dock,
then
the
vaccines
are
kept
in
cold
storage
locally
on
site
and
then
are
ready
to
be
given
to
those
who
choose
to
receive
the
offer
of
the
vaccine.
E
So
the
question
comes:
where
will
vaccines
be
available,
and
this
may
vary
between
between
county
and
city
and
and
local
circumstances,
that
mix
initially
with
scarce
vaccine?
E
It
will
be
a
smaller
number
of
settings,
including
public
health,
sponsored
clinics,
local
health
departments
and
routine
settings,
and
then,
as
vaccine
becomes
increasingly
available,
this
will
feel
more
and
more
like
receiving
seasonal
flu
vaccine
or
other
routine
vaccines,
and
that
an
increasingly
a
larger,
a
larger
number,
a
larger
variety
of
settings
to
receive
your
to
be
be
able
to
have
access
to
to
the
different
covert
vaccines
that
become
available
next
slide.
Please.
E
So,
I
think
bobby
and
the
chairs
received
a
number
of
inquiries
over
the
last
days
regarding
a
piece
in
the
new
york
times.
E
That
discussed
concerns
over
data
sharing
between
states
and
the
cdc
around
vaccine
information,
and
this
is
just
to
emphasize
that
in
california,
in
providing
information
to
the
federal
government
in
order
to
be
able
to
count
the
number
of
doses
that
have
been
given
and
monitor
the
progress
of
the
campaign.
Only
de-identified
data
will
be
shared
with
the
federal
government
next
slide.
Please-
and
I
will
stop
there
and
thank
you
for
your
attention
again,
dr
burke,
harris
or
bobby
you're
erica.
A
Yeah,
thank
you,
dr
schechter.
I'm
sure
there's
lots
of
questions
if
you're
ready
to
answer
them-
and
I
know
in
the
california
association
of
health
plans
has
his
hand
up
and
then
we'll
go
to
anthony
wright.
U
Thanks
bobby
and
thanks,
dr
schechter,
I
appreciate
it.
It's
very
helpful.
I
have
kind
of
three
different
points
I
just
like
to
raise
for
the
group.
You
know.
I
think
this
is
helpful
to
to
know
what
you
guys
are
seeing
for
the
state,
the
state's
allotment
of
the
initial
shipment
and
how
you
see
that
sort
of
happening.
U
It's
come
up
a
number
of
times,
I'm
going
to
channel
my
inner
brianna
lehrman
here
and
and
and
say
we
do
still
have
a
lot
of
questions
around
the
doses
that
are
coming
to
the
long-term
care
facilities
and
how
those
are
going
to
get
allocated.
It
would
be
very
helpful
if
you
guys
could
identify
someone
if
it's
not
you
who
could
speak
to
how
that
process
is
going
to
work
so
that
we,
you
know
providing
coverage
to
all
these
enrollees
would
know
number
two.
U
U
You
know
when
you're
talking
about
300
000
doses
versus
40
million
doses,
it's
a
huge
huge
jump
and
it's
important
that
all
of
us
as
we
go
down
this
path.
We
keep
in
mind
that
we
have
to
bring
this
thing
up
to
scale
and
then,
finally,
on
the
on
the
privacy,
I
think
we
we
as
health
plans
would
be
would
be
curious,
doesn't
have
to
be
answered
today.
Your
thoughts
about
the
privacy
of
patient
data
as
it
pertains
to
the
vaccine
between
related
health
healthcare
entities
providers,
health
plans.
U
Are
we
going
to
be
able
to
to
know
when
someone
has
received
the
vaccine
so
that
we
can
prepare
for
any
adverse
reactions?
So
we
can
prepare
for
you
know,
making
sure
that
we
understand
what's
happening
with
with
the
with
the
general
population.
So
those
are
kind
of
three
different
things
there
for
you
guys
to
consider,
and
thank
you
very
much
for
allowing
me
to
speak
appreciate
it.
E
E
Part
of
the
one
of
the
contractual
agreements
that
providers
signing
in
california
or
nationwide
to
receive
vaccine
is
agreeing
to
enter
data
into
the
california
immunization
registry,
which
is
a
few
databases
and
that
are
encompass
the
state
so
that,
whether
whether
directly
or
through
an
ehr
or
through
another
export.
E
So
there
will
be
that,
along
with
the
the
reminder,
notes
and
the
the
proof
of
immunization
that's
given
at
the
time
of
the
immunization.
These
doses
are
to
be
recorded
into
the
the
immunization
registry
and
would
be
it's
an
accessible
source
for
for
providers
to
search
on
a
search
on
somebody
who
believes
they
got
their
their
first
dose
in
a
different
setting
at
an
earlier
time.
E
E
Most
most
facilities
have
signed
up
to
participate
in
this
program,
two
to
large
chain
pharmacies
in
california,
the
are
the
the
vaccinators,
the
the
the
participating
immunization
teams,
and
that
once
that
program
starts,
that
doses
are
taken
from
california's
allocation
to
to
give
to
that
program
so
that
they
have
a
pool
of
doses
for
their
teams
as
they
set
aside
for
them,
as
their
teams
take
on
these
thousands
of
facilities
around
the
state.
E
So
that's
a
that's
a
highest
level
outline
and
if
there
are
additional
details
we
can
try
to
provide.
E
I
would
ask
you
to
include
your
questions
in
the
chat
and
then
the
second
element.
I
might
I
can't
recall
what
number
two
was:
pharmacy:
partnership,
tracking
doses
and
information
flow
and
I'm
sorry,
I'm
I'm
missing
the
middle.
The
middle
element.
U
Yeah,
I
was
just
raising
that
you
know
we
have
to.
It
gets
a
lot
more
complicated
in
tracking
all
of
this
when
we
go
from
300
000
enrollees
to
you
know,
38
million.
A
Thanks
charles
for
bringing
up
those
important
issues,
we're
going
to
go
to
anthony
wright
and
then
I'm
going
to
call
on
a
few
other
people
in
order
we're
going
to
try
to.
We
have
a
lot
of
people
who
have
comments
and
we
don't
have
a
huge
amount
of
time.
A
As
you
know,
so
I'm
going
to
try
to
go
to
some
of
the
folks
whose
voices
we
haven't
heard
today
so
from
anthony,
we'll
go
to
brianna
and
then
jake
and
then
sylvia
and
then
we'll
see
how
much
more
time
we
have
to
go
on
to
others
in
the
bridge.
Go
ahead,
anthony
introduce
yourself.
V
Anthony
wright
executive
director
of
health
access,
california
pronunciation.
Thank
you
for
all
this
really.
V
Important
information-
and
I
put
my
question
in
the
chat
but
just
to
say
it
out
loud
the
I
mean
I
think
I
appreciate
that
you
know
the
pharmacies
and
the
clinics
and
the
infrastructure
we
have
for
the
flu.
Vaccines
is
the
infrastructure
we
have,
and
that
is
bad
and
that's
important
for
the
for
the
widespread.
But
it
seems
that
for
the
first
tranche
we
have
maybe
a
distributional
advantage
that
maybe
we're
not
taking
advantage
of,
which
is
that
this
is
very
worksite
based.
V
You
know
people
at
healthcare
facilities,
people
at
long-term
care
facilities,
and
so
it
seems
like
bringing
the
vaccine
to
them
and
using
that
the
fact
that
everybody's
geographically
co-located
in
these
areas
could
be
beneficial,
especially
if
you're
going
to
have
to
do
two
rounds
at
a
facility
to
a
work
to
a
workforce
to
a
work
site,
and
so
I'm
I'm
just
curious
about
if,
if
like
it
seems
like
there
would
be
a
lot
of
leakage
and
a
lot
of
that.
V
We
would
miss
people
if
we're
sending
workers
from
health
facilities
to
clinics
and
pharmacies
and
whatever
to
go,
get
their
vaccinations
rather
than
to
do
it
at
the
work
site.
I
also
think
there's
probably
logistical
issues
with
long-term
care
facilities,
etc,
and
so
we're
just
curious
about
if
that's
possible
or
doable
or
whatever,
and
then
there's
a
second
question
to
that
which
is
in
regard
to
timing.
If
there
are
side
effects,
as
we've
discussed,
how
do
we
make
sure
that
we're
not
hitting
one
facility
with
side
effects
all
at
the
same
time.
E
Two
really
critical
questions
and
issues.
I
think
you'll
see
as
the
61
local
health
departments
plan,
their
their
local
responses
and
build
up
their
either
directly
or
with
partners.
Work
up
sort
of
a
surge
capacity
to
build
on
the
existing
infrastructure.
E
There'll
be
a
combination
of
settings
where
there's
teams
going
out
to
the
field,
whether
to
the
workplace
or
other
sites
in
the
community
to
meet
to
meet
the
to
meet
those
who
need
who
would
need
or
benefit
from
vaccination,
as
well
as
central
sites
to
invite
people
to
come
in
and
that
it
will
be
a
a
combination
and
to
that
to
that.
E
E
E
In
fact,
it
works
workforce
implications,
yeah
yeah,
so
the
advisory
committee
on
immunization
practices
is
it
advised
considering
staggering
immunization
efforts
to
for
the
for
your
concern
very
concerned
you're
raising
about
if
you
had
a
lot
of
staff
out
with
with
flu
symptoms
or
aches
and
pains
and
chills
for
a
day
or
two,
and
so
I
it'll
be
challenging
to
implement.
E
So
it's
all,
I
can
important
consideration
and
how
to
how
to
structure
this
in
a
staggered
or
other
fashion,
or
offering
vaccine
on
in
timing
around
days
at
work
versus
days
off
and
and
challenging
logistics
that
I
imagine,
you'll,
be
seeing
a
lot
of
a
lot
of
that
staggering
going
on
in
to
to
meet
those
local
local
workforce
concerns
and
maintain
maintain
capacity
in
these
critical
settings.
V
I
mean
I
would
just
just
to
make
a
comment
and
then
let's
move
on,
but
I
just
I
think,
especially
if
we
are
going
to
try
to
stagger,
then
that
works
like
public
health
approach
to
distributing
the
vaccine,
makes
more
sense
than
sort
of
the
like
the
the
clinical
go
out,
and
I
know
that
that
might
create
more
headaches
for
my
colleague,
charles
and
brianna,
with
regard
to,
because
not
everybody
in
the
same
facility
is
insured
by
the
same
entity,
and
so
there
might
not
be
some
some
back
end
figures.
V
But
I
do
think
that
if
the
point
I'm
sure
we
could
figure
out
the
the
sort
of
the
coverage
and
financing
of
the
vaccine
piece.
But
I
wouldn't
want
that
to
get
in
the
way
of
getting.
You
know
getting
people
this
in
the
most
effective
way
and
also
in
a
way
where
we
can
control
the
timing.
So
we're
not
messing
up
our
facilities
and
so
that,
that's
just
simply
my
point.
L
A
And
thank
you
rob
for
answering
these
questions,
as
specifically
as
you
can
we're
going
to
go
to
brianna
and
then
jake
and
then
sylvia
brianna,
please
introduce
yourself.
M
W
Charles
you
did
a
pretty
decent
job
channeling
me
thank
you,
and
I
actually
want
to
build
on
anthony's
comment
and
talking
about
you
know
why,
from
the
payer
perspective,
we
are
so
anxious
to
know
the
details.
It's
because
we
don't
want
to
interrupt
the
process
on
the
ground
when
this
all
starts
rolling
very,
very,
very
quickly
and
we're
still
playing
catch-up.
We
had
a
call
yesterday
with
all
of
our
ceos
and
all
of
our
cmos,
and
it
was
almost
like
pooling
resources
to
understand.
What's
going
on,
what
have
you
heard?
W
What
have
you
heard
filling
in
the
blanks
in
the
details?
That's
really
scary
for
us,
so,
just
as
an
example
on
administration,
long-term
care
facilities,
that's
coming
within
a
couple
of
weeks,
the
vast
majority
of
those
individuals
are
covered
by
the
medical
program.
We've
had
no
conversation
in
the
medi-cal
program
of
what
that's
going
to
look
like,
and
the
cdc
guidance
says
that
cvs
and
walgreens
are
going
to
bill
the
payers
and
we're
not
interjecting
ourselves,
because
you
know
we're
we're
curious
about
the
billing.
W
It's
because
of
all
the
logistics
that
go
that
building
those
partnerships
and
making
sure
it's
smooth
on
our
end,
so
our
members
and
your
and
the
patients
can
get
the
vaccine,
and
this
is
also
how
we
build
on
how
we
get
to
the
1b
population
and
the
1c
who
are
really
medical
members
and
that's
a
big
population,
and
it's
going
to
be
fast
and
serious.
So
I'm
sorry,
dr
barcares,
on
a
broken
record
on
asking
for
details.
W
We
don't
want
to
screw
this
up
on
the
ground.
Building
logistics
takes
time.
We
can
do
it
quickly.
We
can't
turn
on
a
dime,
but
just
to
underscore
dr
schlechter
and
others
said
we're
ready
to
be
partners.
We've
done!
That's
why
we
want
this
detail
so
whenever
it
can't
be
provided
or
inside
and
when
it
will
be
provided
this
slide
meant
nothing
about
payer
side.
We
don't
want
to
be
the
reason
anything
has
a
hiccup.
So
that's
it.
A
X
All
right
thanks
a
lot
I'd
like
to
ask
a
question
about
the
sharing
of
information,
in
particular
the
identity
identified
information
with
with
the
federal
government
as
sort
of
described
in
the
in
the
new
york
times,
piece
that
is
linked
to
in
the
slide.
You
know
it's.
X
I
think
it's
very
good
news
that
california
sounds
like
his
push
back
on
some
requests
for
information
that
appear
to
be
over
broad
and
unnecessary
from
the
federal
government
in
terms
of
name
and
address
that
that
would
be
would
have
been
provided.
So
that's
good
news,
and
I
appreciate
that
I'm
sure
hard
work
from
the
department
of
public
health
and
lots
of
others.
X
I
wonder
if
there
might
be
an
opportunity
either
on
this
call
or
afterwards
to
explain
a
little
bit
more
about
what
that
identification
looks
like
what
the
dna
identification
approach
is.
That's
anticipated
to
be
used
here,
because
you
know
de-identifying
information
is
kind
of,
is
very
difficult
task
and
it's
actually
kind
of
a
sliding
scale,
and
so
there's
levels
of
identification,
and
just
one
kind
of
example
of
that
is
that
it
turns
out
that
birth
date,
gender
and
zip
code.
X
Just
that
information
about
a
person
without
their
name
or
address
or
anything
else,
is
identifiable
for
85,
approximately
85
of
the
population
and
in
the
the
data
use
agreement
that
was
was
linked
to
in
that
piece.
It
shows
that
that
that
zipcode,
gender
and
and
birth
date
are
shared
with
the
federal
government,
and
so
that's
sort
of
an
example
of
something
that
might
not
intuitively
seem
identifiable,
but
in
fact
it
is
for
a
large
portion
of
the
population.
X
So
I'm
curious
what
kind
of
what
exactly
the
the
identification
process
is
and
then
what
exactly
the
information
is
that
would
be
shared
with
the
federal
government.
Thanks
a
lot.
A
E
I
don't
have
the
list
of
the
data
fields
at
hand
that
are
being
collected,
but
I
can,
I
know,
the
the
process
of
close
review
that
that
has
gone
on
to
modify
the
to
modify
the
data
use
agreement
so
that
so
that
identifiers
have
been
removed.
But
I
I
I
can't
I
don't
have
the
details
of
the
fields
to
be
able
to
address
specifically
the
example
of
data
birth,
zip
and
engender.
A
N
X
Can
I
can,
I
just
also
add
that
there's
there's
the
question
of
collection
of
that
information
in
california
and
then
there's
a
question
of
sharing
it
with
the
federal
government,
and
it
might
be
that
more
is
collected
than
shared
and
so
there's
kind
of
two
two
questions.
What's
what's
collected
and
kept
in
california
and
then
what's
collected
and
potentially
shared,
and
then
what
can
you
know
cbc
or
ehhs
do
with
that
information
once
they
have
it
under
the
contract?
X
How
might
it
be
shared
outside
of
those
two
public
health
agencies?
So
those
are
the
kind
of
those
are
the
general
questions
and
appreciate
the
follow-up.
A
Great
next
week,
so
much
for
pushing
this
along
and,
as
I
said,
I
know,
other
members
of
the
committee
are
very
interested
in
this
issue.
So
let's
hear
from
sylvia
and
then
we're
going
to
have
to
move
on
to
the
phase
1b
discussion.
So
for
those
of
you
that
we
didn't
get
to
on
this
round.
Please
put
your
issues
in
the
chat
and
we
will
address
them
as
we
can.
Sylvia.
Y
Hi,
I'm
sylvia,
I'm
a
senior
staff
attorney
with
disability
rights,
education
and
defense
fund.
I've
been
trying
to
avoid
the
sort
of
three-part
pattern,
but
I
I
seem
to
have
fallen
into
it.
One
of
the
first
questions
is
I'm
trying
to
figure
out.
Will
it
be
the
providers
who
will
have
the
responsibility
of
verifying
that
an
individual
who
comes
to
them
for
a
vaccination
actually
falls
within
the
priority
category
that
they're
vaccinating
at
the
time
or
or
if
they're,
going
to
a
to
a
nursing
home
or
to
a
location?
Y
Does
that
location
tell
them?
How
many
doses
is
needed?
I
I
I'm
just
trying
to
figure
out
how
this
will
actually
work
and
and
then
because,
once
a
vaccination,
the
vaccination
is
out,
at
least
for
the
pfizer
there's
only
five
days.
I
can
survive
it
at
survive
once
it's
out
of
deep
freeze,
what
is
sort
of
the
level
of
discretion
that
and
who
gets,
who
gets
discretion
over
the
doses
that
are
sort
of
left
that
aren't
used
and
then
need
to
be
used
with
within
five
days.
Y
I
this
this
the
interaction
of
verification
discretion
and
of
the
who,
under
the
county,
what
the
level
of
discretion
that
a
county
has
is
is
a
bit
of
a
black
hole
for
me.
So
those
are
the
first
two
and
the
third
one
in
a
way
deals
with
discretion
as
well.
Y
In
1a,
we
all
agreed
about
long-term
care
facilities
falling
with
one
in
one,
but
but
there
are
a
very
great
range
of
long-term
facilities
from
intermediate
care.
Facilities
to
nursing
facilities
which
are
large
to
small
group
homes
are,
are
counties
deciding
individually,
who
falls
in
to
the
long-term
care
facility
category
and
therefore
in
180
and
I'll
leave
it
at
that.
E
E
Then
there
there
typically
will
be
some
more
flexibility
in
terms
of
the
questions
of
of
storage
and
and
counts,
and
matching
matching
the
number
of
patients,
the
doses
per
vial
and
and
those
sort
of
considerations
that,
when
doses
are
coming
out
of
being
brought
out
to
the
field
like
a
long-term
care
facility,
that
there
will
be
some
coordination
between
the
the
immunizing
team
and
the
facility
to
get
counts
ahead
of
time
and
to
try
and
match
the
match.
E
The
doses
closely
to
the
to
the
need
at
the
particular
site
in
terms
of
the
who's,
validating
who's,
validating
identity
or
qualification,
within
a
group
in
in
other
in
other
settings
that
that
will
vary
and
some
and
sometimes
it
will
be
worker
lists
or
patient
lists
and
another
other
other
times.
It
will
be
up
to
the
up
to
the
provider
of
the
immunizing,
the
immunizing
clinic,
to
follow
to
follow
the
the
there's
again.
Another
contractual
agreement
of
the
providers
is
to
to
follow.
E
Prioritization
guidelines
in
order
to
receive
vaccine
so
at
times
it
will
be
the
the
immunizers
who
are
put
in
the
position
of
verifying
qualification
for
for
for
being
in
the
priority
group,
and
so
those
are
some
of
your
questions.
May
I
ask
you,
which
other
ones
would
be
helpful
to
try
and
clarify.
Y
Thank
you.
I
I,
the
third
category
was,
was
talking
about
how
much
discretion
counties
have
to
decide
who
fault
what
long-term
care
facilities?
What
that
comprises
for
category.
E
So
there
is,
there
is
guidance
on
on
long-term
care
in
terms
of
licensing
categories,
but
I
I
don't
think
our
guidance
currently
has
all
has
all
variations
on
congregate
living
there.
So
there
may
be
this
at
this
point.
There
may
be
uncertainty
or
discretion
at
the
local
level.
E
E
Y
A
B
Thank
you
bobby.
It
really
are
excellent
questions.
You
know
there
there's
so
many
questions
that
folks
are
raising
that
are
really
thoughtful.
B
There
are
so
many
issues
about
how
do
we
move
this
work
forward
and
we've
done
our
best
in
in
organizing
these
meetings
to
make
sure
that
there's
you
know
enough
time
so
that
we
can
present
you
with
enough
information
that
you
all
can
be
thoughtful
in
informing
this
process
and
at
the
same
time,
offering
enough
time
for
discussion
and
conversation,
so
we're
we're
doing
our
best
to
balance
that
coming
into
the
meeting
at
the
beginning
of
the
meetings,
we
saw
lots
of
questions
in
the
chat
about
you
know
who
falls
in
what
category
and
who's
in
one
a
and
who's
in
one
b.
B
So
we
really
wanted
to
make
sure
to
leave
a
good
amount
of
time
for
this
conversation
about
the
discussion
of
phase
1b
and
looking
at
the
criteria
regarding
essential
workers,
and
so
now
I
want
to
introduce
dr
ron
chapman
from
california
department
of
public
health
who
will
share
who's
going
to
share
more
about
this.
B
I
want
to
remind
members
that
at
our
first
discussion
with
the
at
our
at
our
meeting
last
week,
our
conversation
preceded
the
drafting
guidelines,
work
group
and
that
they
really
took
the
the
information
and
the
insights
the
concerns
shared
from
everyone.
As
part
of
this
committee,
into
their
deliberations
in
the
drafting
guidelines,
work
group
and
and
on
friday,
this
coming
friday.
B
The
drafting
guidelines
work
group
will
meet
again
and
they
will
be
informed
by
everything
in
this
discussion
and
then
they
will,
at
our
next
meeting,
they'll
provide
guidance
for
our
discussion
based
on
their
deliberations
about
the
prioritization
of
sectors.
B
And
so
I
want
to
remind
everyone
that
we
are
talking
about
sectors
outlined
by
the
governor
in
in
march
of
2020.
We're
not
talking
about
the
specific
occupations
at
this
time,
but
rather
looking
at
the
sectors
when
we're
thinking
about
essential
workers
for
phase
1b
and
then
and
that
members
were
sent
a
list
of
essential
workers,
sectors
that
was
developed
by
the
governor's
office
in
march
of
2020.
B
And
so
with
that
as
a
grounding
I'll
go
ahead
and
kick
it
over
to
dr
chapman
to
start
to
review
the
data.
Since
our
last
meeting-
and
I
know
that
dr
brooks
will
be
joining
us
a
little
bit
later
after
he's
completing
another
another
meeting,
dr
bro,
dr
oliver,
brooks
from
our
who's
the
co-chair
of
our
drafting
guidelines,
work
group.
Z
Thank
you,
dr
burke,
harris
and
so
I'll
be
presenting
several
slides
on
the
data
that
we've
gathered.
That's
a
profile
of
essential
workers
in
california.
To
help
all
of
you
inform
your
your
thinking
and
decision
making
and
some
of
this
data
I
presented
at
our
previous
meeting.
There
are
several
new
members,
and
so
this
will
be
new
for
those
folks.
First
time
at
this
meeting,
so
it'll
be
a
refresher
as
well.
We've
updated
some
of
the
data
thanks
to
your
input
and
and
added
some
data.
So
if
I
could
have
next
slide,
please.
Z
This
is
the
list
that
dr
burke
harris
is
referring
to
from
the
governor's
order,
from
the
stay-at-home
order
in
march
and
april
includes
a
number
of
essential
worker
sectors,
emergency
services,
food
and
agriculture,
energy,
waste
and
wastewater
transportation,
logistics,
communication,
information
technology
because
of
the
interest
in
education
and
child
care.
We
actually
pulled
that
out
of
the
government
operations
and
community-based,
essential
functions,
sector,
critical,
manufacturing,
financial
services,
chemical
and
hazardous
materials,
defense,
industrial
base
and
industrial,
commercial,
residential
and
sheltering
facilities
and
services.
Z
Z
So
the
sectors
that
I
just
showed
within
those
are
dozens
and
dozens
of
occupations,
and
I
just
want
to
point
out
the
difference
and
the
example
that's
given
on
the
bottom
is
a
good
one.
For
instance,
if
a
truck
driver
works
for
a
lumber
company,
the
industry
may
be
called
forestry
and
logging,
but
the
occupation
is
transportation
and
an
accountant
working
for
the
same
lumber
company
would
have
an
occupation
categorized
as
business
and
financial
operations.
Z
Z
So
I
showed
this
slide
last
time
and-
and
this
gives
a
sense
of
the
total
numbers
of
folks
that
we're
looking
at
for
for
some
of
these
and-
and
I
showed
this
slide
last
time
and
got
a
lot
of
feedback
from
folks
that
the
agriculture
numbers
looked
really
low.
So
we
went
back
and
looked
at
some
other
information
and
and
we're
looking
at
now
about
a
million
folks
under
agriculture,
1.3
million
in
education,
150
000
in
first
responders,
like
police,
california,
highway
patrol
fire
and
ambulance
and
then
other
workers,
5.7
million
and
the
next.
Z
And
I
I
just
want
to
emphasize
again
that,
when
we're
looking
at
ag
workers,
there
was
a
uc
davis
study
that
we
were
referred
to
again.
Thank
you
to
members
of
this
advisory
committee
where,
where
they
stated
that
california
has
a
complex
farm,
labor
market
in
which
nearly
1
million
workers
fill
an
average
of
425
000
full-time
equivalent
jobs,
we
followed
up
with
those
uc
davis
researchers,
there's
no
updated
information.
Z
Z
Z
Shows
a
breakdown
of
what
those
other
workers
really
look
like
so
2.2
million
in
the
community-based
and
government
operations,
education,
1.3,
agriculture,
989,
000,
critical,
manufacturing
about
800
000,
and
you
can
see
going
through
this
graph
food
and
grocery
150
000
electricity,
160
000-
and
this
just
gives
you
a
sense
of
the
size
of
some
of
these
occupations
and
sectors
based
upon
the
data
sets
totaling
of
essential
workers
about
8.2
million
people
in
california.
Next
slide,
please.
Z
Z
Z
Most
of
the
workers
employed
in
agriculture
do
not
work
year-round
and,
of
course,
we
know
as
well.
There
are
undocumented
people
working
in
agriculture
and
it's
really
hard
to
know
exact
numbers
there
and,
of
course
this
is
a
group
that
is
going
to
need
outreach
in
order
for
them
to
access
vaccine
and
language
and
culturally
appropriate
vaccine
information
to
help
them
decide
whether
they
want
the
vaccine
or
not.
Next
slide.
Please.
Z
This
is
a
slide
showing
the
geographic
distribution
of
agriculture
workers
and
365
000
are
in
the
southern
san
joaquin
valley.
So
that's
the
majority
of
folks
next
to
the
central
coast,
213
000
and
then
the
northern
san
joaquin
valley,
approximately
128
000.
So
we
know
there's
a
geographic
difference
when
you're
looking
at
agriculture
workers
next
slide.
Please-
and
this
is
the
pie
chart
showing
the
agricultural
workers
by
county
and
where
they
are
distributed.
Geographically,
fresno
113,
000
kern,
county
151,
000
la
40,
000,
monterey,
102
000.
Z
This
is
also
from
the
uc
davis
report,
and
this
shows
workers
by
county
over
the
entire
state,
agriculture
workers
and
the
dark
green
are
the
counties
with
the
largest
population
of
agriculture
workers
and,
as
the
previous
slide
shows
it's
it's
mostly
in
the
central
valley,
san
joaquin
valley
area.
Next
slide,
please,
okay.
These
slides,
I
showed
previously
and
again
some
folks
are-
are
attending
for
the
first
time
at
this
meeting.
So
I
wanted
to
make
sure
I
included
these
from
the
uc
berkeley
labor
center,
and
this
is
again
a
different
data
set.
Z
So
you
know
many
of
these
are
occupations
within
that
we
would
find
within
certain
sectors,
but
I
thought
this
was
really
important
information
to
help
guide
and
inform
your
thinking
when
it
comes
to
this
upcoming
conversation,
we're
about
to
have
about
the
risk
criteria
for
how
to
prioritize
these
sectors,
and
this
shows
low
wage,
so
percentage
of
front
line,
essential
jobs
that
are
low
wage
shows,
for
example,
farm
workers.
80
percent
are
low
wage
janitors
and
building
cleaners.
Z
Z
From
the
same
report
from
uc
berkeley
labor
center-
and
I
thank
them
for
allowing
us
to
share
this
information
with
all
of
you.
This
slide
shows
race,
ethnicity,
of
frontline,
essential
workers,
again
farm
workers,
93
latinx,
construction
workers,
78
latinx,
cooks,
69,
latinx,
food
preparation,
workers,
64
latinx,
and
you
can
see
as
you
go
down
through
all
of
these
different
occupations,
how
the
race,
ethnicity,
spread
changes.
Z
Also
from
uc
berkeley,
labor
center
percent
of
front
line,
essential
workers
that
are
immigrants,
farm
workers,
81
percent,
food
preparation,
workers,
55
construction,
laborers,
55,
cooks,
54
and
the
numbers
the
percentages
decrease
from
there,
and
these
are
the
the
top
15
occupations
that
they
listed
in
this
labor
center
report
next
slide.
Please.
Z
Z
Z
Z
Please
and-
and
this
is
age-
and
I
think
everybody's
aware
that
with
increasing
age,
there's
increasing
risk
of
hospitalization
and
death
and
again
this
is
data
from
cdc.
That
concludes
my
presentation
on
data.
I'm
happy
to
answer
questions
and,
if
folks
feel
like
they
need
additional
data
to
help
with
informing
decision
making.
We've
got
a
fantastic
data
team-
that's
been,
you
know,
really
digging
in
through
the
literature
and
reports
and
trying
to
extract
what
we
feel
is
most
relevant
to
help
all
you
of
you
with
your
thinking
around
these
challenging
subjects.
A
Ron,
we're
gonna,
take
a
couple
of
questions.
I'm
gonna
ask
mitch
steiger
and
ronnie
kelly
to
start
and
then
we'll
see
how
much
time
we
have,
because
we
have
more
work
to
be
done
on
the
criteria
for
essential
workers.
But
let's
see
if
we
can
get
a
couple
of
questions
by
a
few
people
who
we
haven't
heard
from.
AA
Thank
you
mitch,
steiner
with
the
california
labor
federation.
I
think
my
hand
was
still
raised
from
the
last
one,
but
it's
kind
of
the
the
same
issue
with
this
one,
which
is
we.
We
should
really
start
thinking
about
how
we're
going
to
even
get
vaccine
doses
to
workers
based
on
occupation,
that
even
in
healthcare,
it's
going
to
be
really
really
challenging,
where
there
may
be
some
way
of
keeping
workers.
Privacy,
safe
and
using
site-specific
location.
Information
like
anthony
was
talking
about
to
get
it
to
the
right
people.
AA
But
when
we're
talking
about
eight
million
workers,
many
of
whom
are
paid
under
the
table,
there's
no
way
to
prove
any
of
them
do
what
they
do
for
a
living.
Even
if
we
didn't
want
to
try
to
enforce
anything
like
that,
and
so,
which
kind
of
leaves
us
with
the
honor
system.
And
I
that
that's
going
to
be
a
an
issue,
because
if
we
just
say
okay,
everyone
who
works
in
one
of
these
industry
classifications
come
on
down
and
get
a
vaccine
boy
like
that.
AA
That's
going
to
be
a
big
mess
and
that's
going
to
lead
to
a
lot
of
different
problems.
But
it's
kind
of
the
only
option
we
have
so
I
don't.
I
don't
have
any
idea
what
the
answers
are,
but
we
really
need
to
start
thinking
about
it,
because
we've
got
a
really
limited
amount
of
time
to
figure
out
what
we
do
and
we
just
urge
that
workers
and
the
representatives,
particularly
unions,
are
involved
in
that
discussion.
A
Okay,
let's
go
to
ronnie
and
then
we'll
go
to
lisa
hershey.
A
AB
Hi
everyone
lisa
hershey
with
housing,
california,
dr
chapman,
really
appreciate
the
data.
I
was
doing
some
deeper
research
just
to
have
a
better
sense
of
essential
workers
in
the
context
of
affordable
housing
and
homelessness
and
how
this
plays
out
and
and
talk
to
one
of
my
board
members,
dr
margot
couchell,
who
does
research
in
this
area
all
the
time
and
one
of
the
things
she
pointed
out
to
me.
AB
That
I
think
is
really
relevant
to
this
conversation
is
that
essential
workers,
particularly
low
wage,
essential
workers,
live
in
overcrowded
conditions,
and
so
the
big
super
spreaders
when
she
she
actually
did
some
of
the
tracing
early
on
and
found
that
one
person
working
low-wage
jobs
is
living
in
a
household
with
10
to
14
other
people
with
one
bathroom,
and
so
particularly
in
the
latinx
community,
black
and
brown
communities.
Such
a
super
spreader
impact,
and
so
I
know
that
goes
outside
just
thinking
about
our
sectors.
AB
They
are
working
so
they're
going
to
their
essential
jobs
and
then
coming
back
to
the
homeless,
shelters
and
that's
a
congress
said
that's
a
super
spreader
experience
as
well,
and
so
I
just
felt
like
that
was
a
really
important
variable
from
a
population-based
perspective
and
as
we
think
about
this
construct
within
which
we're
making
decisions,
how
who's
being
impacted
again
are
saying
black
and
brown
communities
and
where
are
those
impacts
happening,
and
I
also
gather
some
other
inputs
on
people
experiencing
homelessness,
etc
and
and
people
currently
shelter
that
will
end
up
homeless.
Z
Yeah
thanks
lisa
those
are
really
great
points
and
and
can
be
used,
I
think,
to
to
drive
some
of
the
planning
at
the
local
level
in
terms
of
outreach
and
identifying
some
of
those
those
areas
of
housing
where
there
is
overcrowding
and
and
trying
to
get
the
vaccine
to
folks
in
those
sites.
I
know
anthony
wright
mentioned
the
workplace,
but
what
you
just
brought
up
is
just
another
geographic
type
approach
to
get
to
folks
to
get
them
vaccinated.
So
thank
you.
A
AC
Thanks
bobby
melissa,
stafford
jones
with
the
first
five
association
of
california,
I
really
appreciated
reviewing
again
the
data
from
uc
berkeley,
with
some
of
the
framing
that
was
provided
leading
into
it.
One
of
the
things
I
noticed,
though,
is
that
there
are
a
number
of
those
occupations
and
industries
that
are
not
captured
in
that,
and
I'm
just
wondering
if
there's
an
opportunity
to
try
to
find
some
other
data
sources
that
maybe
brought
in
that
look.
AC
I'm
like
I'm
noticing
that
child
care
workers
were
not
included
there,
but
we
know
that
the
vast
majority
of
child
care
workers
are
low
wage,
mostly
women
and
mostly
women
of
color.
So
I'm
just
curious
and
I'm
sure
it's
not
just
child
care
workers.
There's
probably
some
others
too.
Is
there
some
opportunity
as
we're
doing
some
of
this
trying
to
be
thoughtful
about
the
prioritization,
if
there's
more
data
that
perhaps
could
shed
some
light
on
other
occupations
and
industries
of
essential
workers.
Thank
you.
Z
A
A
I
I'll
take
the
opportunity
to
ask
a
related
question
implied
in
our
working
through
1b
on
essential
workers
is.
Does
that
mean
that
1b
will
only
be
essential
workers
because
previous
guidance
had
indicated
that
1b
would
also
include
high-risk
individuals
and
I'm
not
quite
sure,
if
we'll
be
talking
about
a
1c
later
or
if
we'll
be,
how
that
all
will
work
out?
So
I'd
appreciate
clarity
on
that
I
know
it's
been
on
a
lot
of
people's
minds.
Thank
you.
Z
E
AD
E
High-Risk
groups,
as
well
looking
looking
back
a
few
months
ago
when
they
were
all
lumped
together
and
realizing
that
that
there
may
be
within
these
larger
groups,
there
may
be
higher
very
high
risk
groups
within.
So
it's
open
for
consideration.
A
Danny,
I
think
that
was
on
a
lot
of
people's
minds
and
we'll
we'll
see
how
we
can
tackle
that.
Also
at
the
next
meeting.
Okay
dave
off
to
you.
P
Thank
you
again.
This
is
nandy
singh
with
the
chicago
movement
in
terms
of
even-
and
I
know
a
lot
of
my
colleagues-
I'm
gonna-
probably
second
them
when
the
time
comes
in
terms
of
talking
about
agriculture
workers,
but
I
specifically
want
to
when
we
talk
about
food
and
agriculture
workers.
P
I
really
really
want
to
underline
those
in
the
poultry
and
meat
industries,
because
the
structural
system,
in
terms
of
how
those
workers
are
set
up,
is
a
little
bit
different
than
even
some
of
the
other
food
processing
industries,
and
I
I'm
just
constantly
getting
distressing
news.
We've
had
outbreaks
in
fresno
outbreaks
in
livingston,
specifically
around
like
foster
farms,
I'm
getting
texts
from
friends
and
family
members,
testing
positive
they're
unreachable,
currently
at
their
job
locations
and
and
what
you
also
you
just
have
this
structural
mess.
P
That's
been
where,
in
terms
of
the
politicization
of
how
meat
and
poultry
workers
have
been
essentially
in
some
ways,
almost
compelled
to
work
in
in
in
very
dangerous
conditions.
I
I
really
want
to
underscore
that
particular
group
and
as
well
as
truck
drivers,
who
who,
even
if
in
certain
regions
and
states
where
we
begin
to
have
under
control
that
are
constantly
going
across
the
country
if,
if
not
even
crossing
international
borders,
depending
on
what
their
specific
route
is.
P
But
but
again
I'm
going
to
echo
so
many
others.
But
I
really
am
going
to
underscore
just
just
the
constant
heartbreaking
news
we
get
from
the
especially
from
meat
and
poultry
workers.
A
E
Thank
you
bobby
and,
as
dr
brooks
joins
us
welcome
to
to
support
the
discussion.
So
at
our
friday
meetings
of
the.
E
Friday,
meetings
of
the
drafting
work
group,
we
took
into
consideration
and
listened
carefully
to
the
criteria
that
have
been
suggested
by
by
you
all
to
help
sort
between
these.
These
different
different
worthy
groups
of
of
workers
and
some
of
them,
the
main
categories
that
rose
to
the
top
were:
what
is
the
societal
impact
of
the
sector
occupation?
E
What
is
the
impact
on
the
economy?
The
importance
to
the
economy
of
that
sector?
Occupation,
equity
concerns,
as
in
as
a
constant
theme
and
a
priority
and
and
occupational
exposure?
What's
both
the
level
of
exposure
on
the
job?
And
what
do
we
know
about
severe
disease
risk
of
severe
disease
and
death,
and
so
with
with
within
these,
are
incorporated
in
a
number
of
times.
E
Within
each
of
these,
these
overarching
concerns
a
number
of
points
that
came
up
in
in
this
in
comments
from
this
from
this
group
and
from
the
drafting
work
group
as
well.
E
And
I
I'll
just
leave
I'll
just
leave
that
up
for
a
second
to
to
to
take
in
the
points
that
were
included
as
bobby
sent
out
the
survey
for
the
last
week
for
the
last
week.
Many
of
your
comments
as
well
I
mean
going
into
this
meeting
today.
Many
of
your
comments
as
well.
E
Have
been
incorporated,
or
can
be
seen
within
these,
these
larger
these
four,
these
four
groups,
these
four
concerns
on
next
slide.
Please.
E
So
the
the
first
question
in
the
survey
that
went
out
to
the
members
this
week
was,
do
you
agree
with
these
core
criteria
again:
societal
impact,
equity
impact
on
the
economy
and
occupational
exposure
risk
of
exposure
in
the
in
that
in
the
workplace
and
a
large,
a
large
response
for
yes,
96
50
51
out
of
the
53
indicating
support,
and
I
believe,
that's
roughly
two-thirds
of
the
of
the
total
membership
on
next
slide.
Please.
E
So
another
question
was:
are
there
additional
criteria
that
you
would
add
to
these
four
and
out
of
the
ten
responses?
E
It
included
many
many
comments
about
taking
into
consideration
the
health
outcomes
which
is
currently
lumped
within
occupational
exposure.
So
what
is
the
risk
of
severe
severe
illness
or
death?
Five
mentioned
geographical
prioritization,
taking
into
account
hot
spots
or
areas
have
been
disproportionately
impacted.
E
Three
re-emphasize
the
concern
around
equity
as
a
lens
within
within
categories,
and
to
raise
the
issue
of
to
what
degree
does
that
job
or
sector
contribute
to
spread
of
the
disease
in
the
community,
and
this
is
a
con
this
for
this
issue
again,
we're
not
certain
yet
to
what
degree
immunization
will
help
with
will
help
with
spread,
as
opposed
to
direct
protection
of
the
person
who's
being
immunized.
E
E
The
question
was
raised
to
the
group
within
these:
should
these
four
criteria
be
treated
equally
or
ranked
in
some
fashion
and
five
out
of
six
within
the
response.
A3
83
voted
yes
to
rank
the
criteria
and
then,
when
asked
to
rank
between
them
would
say
that
that
the
first
three
of
those
received
quite
a
quite
a
lot
of
support
and
were
close
together,
occupational
exposure,
equity
and
societal
impact,
while
further
behind
those.
Those
three
was
the
impact
on
the
economy
of
the
the
job
receptor.
E
Is
that
the
last
slide
bobby?
Is
that.
E
Okay,
so
at
this
point
would
open
it
up
to
responses
and
and
discussion
around
around
the
criteria,
and
there
seems
to
be
consensus
around
using
using
them
and
and
ranking
them
and
with
the
work
group
plans
to
the
drafting
work
group
plans
to
take
this
feedback
to
its
next
meeting
on
friday,
as
it
starts
to
consider
between
different
sectors
and
different
sectors
and
jobs
and
I'll
see
if
dr
brooks
has
had
time
to
to
join
in.
At
this
point,.
A
Dr
brooks
are
you
with
us?
I
don't
think
he
has
joined
yet
I
think
he
won't
be
here
until
5,
30
or
so
so,
maybe
another
few
minutes,
but
is
it
okay?
We
have
a
three
people
who
so
far
in
addition
to
that
questions
have
comments.
A
So
if
we
can
start
with
carol
green
and
then
melissa
and
then
deborah.
AE
AE
I
could
also
I
don't
work
in
the
farm
industry,
but
I
could
see
that
someone
who,
who
is
the
the
manager
has
an
opportunity
to
to
isolate
or
have
less
exposure,
whereas
the
the
people
working
in,
I
think
we
heard
last
time
about
people
being
crammed
into
vans,
and
things
like
that.
So
I
I
just
as
we're
talking
about
industries.
AE
I
just
think
we
need
to
also
consider
how
we
can
equitably
distribute
the
vaccine,
because
it
does
seem
that
you
know
the
people
with
the
power,
probably
the
wider
people,
I'm
just
making
an
assumption,
but
and
the
ones
that
make
more
money
are
also
in
those
industries
and
sometimes
they're
the
deciders.
So
I
just
want
us
to
think
about
that.
AE
A
Carol
that
that's
very
important-
and
I
think,
when
we
looked
at
the
occupational
exposure
and
really
the
examples
of
what
that
means,
one
of
the
examples
that
was
listed
was
those
unable
to
work
from
home.
So
I
think
your
point
is
one
that
we
have
to
take
into
consideration
is
how
do
we
dig
a
little
deeper
into
the
sectors
and
which
employees
in
those
sectors
are
most
at
risk,
so
melissa.
AC
Thanks
bobby
melissa,
stafford
jones,
first,
five
association
of
california-
I
just
wanted
to
maybe
offer
its
food
for
thought
as
we
seem
to
be
building
consensus
around
those
four
criteria,
how
we
might
utilize
them.
I
struggle
to
be
honest
with
the
question
in
the
survey
about
the
prioritization
of
them
because
it
struck
me
that
maybe
we
need
to
have
more
of
a
layering
approach
that
recognizes
the
cumulative
risk
or
cumulative
effect
on
different
industries
or
occupations
across
those
four
criteria.
A
B
Thank
you,
I
think
that's
that's
very
thoughtful.
I'm
gonna
jump
in
just
to
also
remind
the
committee
that
the
the
the
recommendations,
the
recommendations,
will
go
to
the
drafting
guidelines,
work
group
right
so
in
terms
of
how
we're
utilizing
the
criteria,
one
of
the
things
that
we
can
think
about
is
how
we
would
like
them
to
u
to
utilize
this
criteria
so
that
they
can
go
about
the
process
of
of
doing
the
the
rank
order
list
for
phase
1b.
A
M
Okay,
my
name
is
deborah
shade.
I
represent
the
california
school
board
association,
which
represents
a
thousand
education
agencies,
statewide
and
all
elected
board
school
board
members
in
california.
M
You
know,
I
think
I
I
might
be
repeating
what
was
just
said,
but
I
think,
for
instance,
you
know
in
the
school
sector
I
mean
in
the
sector
with
education,
you
could
have
a
ranking
in
all
four
of
those,
so
I
I
think
that
that
is
got
to
be
figured
out
and
I
was
one
of
the
ones
that
did
not
believe
that
we
should
rank
them
because
there's
so
many
of
them
that
have
that
cross-pollination
across
rankings.
I
also
wanted
to
say
that
you
know
I
would
be
supportive
of
system
immunization.
M
A
Thanks
deborah,
let's
go
to
tia.
H
So
again,
like
one
of
the
other
comments,
the
vaccines
aren't
going
to
those
who
have
less
need
if
we
want
to
say
that
from
those
different
industries
and
employer
spaces.
So
I
think
you
answered
that
dr
burke,
but
just
wanted
to
see
if
there's
any
more
clarity
on
whatever
we
decide
here,
how
it's
going
to
trickle
down
to
actually
work.
We
can
give
guidance
at
the
state
level,
but
enforcement
at
the
county
level.
B
Yeah,
so
I
can
jump
in
and
say
that,
certainly
so
with
with
this
group,
as
we
give
guidance
to
the
drafting
guidelines
committee
around
what
the
considerations
are
and
how
we
want
to
be
thinking
about
creating
the
the
list
for
for
1b.
I
think
the
question
of
to
your
point
in
terms
of
the
implementation
right,
one
of
the
pieces-
that's
really
key
is
is
going
to
be,
and
I
think
in
our
next
conversation,
there's
been
a
a
couple
of
mentions
in
the
chat.
B
The
governor's
office
has
worked
hard
to
make
sure
that
communities
are
aware
of,
for
example,
legal
protections,
things
like
paid
time
off
and
and
making
sure
that
folks
are
connected
with
legal
advocacy
groups
that
can
ensure
workers,
rights
and
and,
and
that
is
all
going
to
be
part
of
the
implementation
of
this
process
in
there
you
know
there
are
the
guidelines
that
that
we
are
going
to
inform
as
part
of
this
process,
but
in
addition,
really
making
sure
that
that
that
folks
on
the
ground
and
especially
the
most
vulnerable,
recognize,
you
know
what
the
process
should
be:
they're
they're
informed
they
are
aware
and
and
then
also
have
access
to
to
resources
if
there
are
any
challenges
or
with
any
type
of
implementation.
B
D
Well,
I
greatly
appreciate
that
you
are
taking
the
feedback
that
we
are
providing.
Can
you
all
hear
me?
Yes,
okay,
that
you're
all
taking
the
feedback
that
we're
providing
and
going
back.
So
I
greatly
appreciated
you
going
to
go.
D
Look
at
other
farmworker
data
specifically,
and
the
fact
that
I
raised
an
undercount
the
previous
time-
and
you
actually
listened
is-
is
definitely
something
that
that
we
appreciate-
and
I
wanted
to
add
a
little
bit
more
to
the
data
that
has
been
presented
about
farmworkers,
because
it
also
speaks
to
the
equity
and
occupational
exposure
issues.
D
But
we
sent
out
this
monday
a
text,
a
text,
message
survey
to
folks
who
were
already
on
our
text
messaging
program
and
we
had
over
14
000
respondents
who
were
agricultural
workers
and
80
percent
of
those
were
from
california
and
wanted
to
highlight
something
that
really
struck
me
is
that
13
of
agricultural
workers
had
never
been
to
the
doctor
to
get
a
general
health
check,
and
we
had
you
know
previously
in
in
talking
with
farmworkers.
That
was
an
issue
that
often
has
come
up,
but
now
we're
getting.
D
So
this
is
certainly
important
data
that
I
will
share.
It
is
preliminary
data,
but
I'd
also
like
to
send
you
something
more
specific
and
so
I'll
send
it
to
you
directly
bobby,
so
that
can
be
shared
with
others
and
once
again,
thank
you
so
much
for
providing
the
opportunity
to
provide
feedback.
D
S
E
D
You
capture
that
information.
We
asked
them
non-emergency
room,
so
it
wasn't
about
them
going
to
the
emergency
room
yeah.
We
wanted
to
see
whether
people
were
actually
going
to
go,
get
checked
and
how
often
they
were
actually
seeing
a
doctor
just
because
that
is
through
testimonials
from
farmworkers.
Throughout
the
years,
we've
always
heard
that
there
is
often
fear,
especially
for
those
who
are
undocumented,
to
sometimes
go
to
the
doctor
even
to
local
clinics,
the
fear
of
cost,
the
fear
of
public
charge.
D
Potentially
now
that
that's
been
a
heightened
issue
during
the
current
federal
administration,
so
we
wanted,
to,
you
know,
get
some
some
data
from
those
who
are
now
on
our
list
and
see
what
that
initial
data
showed
so
can
definitely
provide
more
data
about
geogeography
within
the
scope
of
the
folks
who
who
did
respond,
and
that
was
preliminary
data.
We
continue
to
receive
responses
today,.
A
Well,
I
think
that's
just
a
great
source
of
additional
information,
diana,
so
stay
tuned
for
maybe
more
requests
for
feedback
from
that
group
that
you
have
so,
let's
go
to
christina
and
then
aaron
and
then
laura
and
then
we'll
see
where
we
are
dr
tom
to
see.
If
we
have
more
time
for
another
comment,.
T
Thanks
bobby,
this
is
christina
from
cfilc.
I
first
just
want
to
raise
up
that.
This
conversation
is
incredibly
valuable
and
I
know
that
it's
very
hard
for
a
lot
of
us
that
are
working
at
the
intersections
and
wanting
to
raise
a
variety
of
different
multi,
multiple
marginalized
community
members.
T
Maybe
the
population
down
a
little
bit
more
because,
frankly,
if
those
with
home
and
community-based
services
that
are
living
independently
were
in
long-term
residential
facilities,
they
would
be
prioritized
for
the
vaccine.
So
I
just
want
us
to
look
and
possibly
allocate
folks
in
that
population
in
the
1v
category,
rather
than
the
one
c.
A
Thank
you,
christina.
Okay,
let's
go
on
to
aaron.
S
Thank
you,
erin
carruthers
from
the
state
council
on
developmental
disabilities.
Thank
you.
Doctors,
burke,
harris
and
brooks
for
the
priorities
in
one.
A
are
very
expansive
and
they're
brought
in
who's,
considered
a
healthcare
worker
and
thank
you
for
adopting
those
for
this
committee's
feedback,
but
that
also
then
applies
to
who
receives
it,
because
we're
looking
not
just
at
the
individual,
we're
not
looking
just
at
their
job,
we're
looking
at
who
is
in
their
community
who's
in
their
universe,
who
they're
coming
in
contact
with.
S
I
see
that
reflected
in
the
additional
criteria
here
and
dr
burke
harris
thank
you
for
letting
us
know
that
these
our
recommendations
will
go
over
to
the
drafting
guidelines.
Work
group,
if
you
could
also
add
to
that
for
them
to
think
about
it's
the
ecosphere
that
someone's
in
and
I
think
it's
summarizing
a
number
of
the
comments,
that's
what
I'm
seeing
and
and
to
hone
specifically
in
the
ones
that
christina
mills
from
cfilc
just
said.
It's
a
really
important
point.
B
Priority,
thank
you,
and
I
see
that
dr
brooks
has
just
joined
us.
Thank
you,
dr
brooks,
for
stepping
away
from
your
last
meeting
to
join
us
on
this
meeting.
I
know
it's
a
very
long
day,
but
we're
thrilled
to
have
you
join
us.
Thank
you.
AF
A
AG
There
you
go
hi
thanks
bobby
hi.
This
is
laura
curry
with
the
california
teachers
association.
AG
So
I
have
a
question
and
then
a
comment.
First,
I'm
curious
to.
When
do
we
expect
1b
to
roll
out
and
how
many
doses
of
the
vaccine
do?
We
expect
in
california
at
that
time,
and
I
think
the
that
having
a
vision
from
the
state
for
the
1b
rollout
will
be
really
valuable
to
help
give
our
local
health
departments
and
local
areas
a
real
jump
start
and
to
help
ensure
the
interconnectedness
that
many
people
have
already
talked
about
on.
AG
This
call
around
an
implementation
report
or
implementation
approach
that
really
ensures
transparency,
equity,
equity
and
really
operational
efficiency
and
effectiveness,
so
that
it's
easy,
it's
accessible.
We
can
reach
people
and
it's
a
very
smooth
experience,
and
so
you
know
it
is
kind
of
mentioned
before
thinking
about
within
our
school
communities.
AG
How
can
we
make
sure
that
school
staff
and
student
parents
guardians
household
members
who
are
essential
workers
can
be
vaccinated
together
to
give
greater
wraparound
protection
for
for
that
school?
And
we
know
that
you
know
we
really
need
to
give
special
consideration
to
black
latinx,
indigenous
and
other
communities
that
we
know
have
been
really
disproportionately
affected.
So
it
would
encourage
us
to
look
at
the
health
equity
index
that
the
state
is
using
and
other
measures
that
look
at
kind
of
a
burden
of
infection
and
disease
within
our
communities.
A
Thank
you
laura
great
points
to
remember
dr
ton
love
to
hear
from
you.
Q
Thank
you
bobby
and
thank
you
for
the
opportunity
again
to
to
share
some
thoughts.
I've
been
thinking
about
the
the
impact
of
the
decisions
that
we
make
around
1b
and
how
that
impacts.
You
know
community
into
and
and
beyond,
phase
two
and
beyond,
and
I
I
think
that
we
should
really
I
I
love
the
idea
of
talking
and
thinking
about
intersectionality
and
how
and
also
how
the
intersections
between
the
people
who
get
the
vaccine
in
one
a
and
one
b
and
how
that
impacts.
Q
The
other
people
in
the
community
and
and
as
an
example
of
that.
I
I
think
that
our
education
is
a
great
example
of
that,
because
you
know
a
lot
of
a
lot
of
the
people
that
I
take
care
of.
They
they
learn
about
health
from
their
children
and
so
there's,
especially
with
immigrant
families
and
families.
Don't
have
that.
Q
Don't
have
easy
access
to
public
health
information,
they're
learning
that
from
their
children,
they're
learning
that
from
their
teachers
who
pass
it
on
to
the
children
who
then
pass
it
on
to
the
family,
the
other
family
members.
Q
And
so
I
I
hope
that,
as
we
consider
prioritizing
communities
in
one
be
that
we
also
think
about
these,
these
pathways
of
communication
and
trust
building
that
that
exists
and
and
many
of
the
cbo's
understand
these
dynamics,
and
a
lot
of
that
I
feel
the
nexus
of
that
is
actually
in
the
education
system
for
many
of
our
communities.
So
I
just
want
to.
I
want
to
just
build
upon
the
sophistication
of
the
thinking
on
here
and
then
linking
that
to
the
subsequent
phases.
AD
Thanks
bobby
I'm
just
going
to
bring
up
topic,
I
mentioned
earlier
but
question
for
dr
schechter,
given
the
conversation
about
how
decisions
that
we're
using
to
prioritize
allocate
in
1b,
how
is
the
allocation
group,
or
even
the
scientific
review
community,
citing
on
whether
this
vex
these
vaccines
prevent
infection
or
transmission,
because,
depending
on
which
way,
the
group
goes
on
that
it
can
significantly
impact
how
we
decide
which
groups
to
get
it?
E
Thanks
for
the
thanks
for
the
question
in
1a
around
healthcare
workers,
we
we
made
the
assumption
that
that
it
that
was
primarily
disease
and
and
in
the
uncertainty
around
transmission,
to
not
count
on
that.
We've
we've
raised
the
question
in
with
within
the
group
again,
and
so
it's
open
for
further
just
further
discussion.
At
this
point,
we've
been
assuming
direct
effects
rather
than
transmission
effects,
but
that's
not
settled
for
for
moving
ahead.
AF
Thank
you
bobby.
Let
me
make
one
quick
comment
if
dr,
what
dr
tan
said
is
true,
in
other
words,
if
by
giving
it
to
certain
groups
that
may
springboard
it
to
going
to
other
groups,
not
protect
them,
but
really
validate
the
vaccine,
then
that's
something
that
we
will
have
to
think
about,
because
one
of
the
things
we're
dealing.
AA
AF
Is
vaccine
hesitancy
for
sure
I
mean
everyone
knows
that,
so
I
think
I
appreciate
that
comment
and
I
think
we
need
to
kind
of
maybe
think
about
is
one
of
the
reasons
we
thought
health
care
workers
would
be
good
people,
trust
health
care
workers
more
than
anyone
else
for
health
care
advice.
That's
study,
that's
not
you
know
arrogance,
and
so,
if
there's
something
else
along
those
lines
that
will
allow
more
people
to
get
vaccinated
by
vaccine
acceptance,
we
will
we
will
take
that
into
consideration.
So
thanks.
A
B
Well,
I
think
dr
brooks
has
just
joined
the
conversation,
so
it's
not
necessarily
fair
to
ask
him
to
summarize
the
conversation,
but
what
so?
I
will
go
ahead
and
take
a
stab
with
the
caveat
of
recognition
that
I
I
am
not
on
the
drafting
guidelines,
work
group,
and
so
I
can
make
a
a
an
assessment
of
where
we
are,
and
then
dr
schechter
and
dr
brooks.
You
can
tell
me
if
that
sounds
close
to
the
ballpark.
B
So
one
of
the
things
I
do,
I
I
think
that
we've
made
clear
with
with
this
group,
is
really
an
important
piece
about
the
roles
right
that
this
group
is,
is
advising
and
and
really
having
this
discussion
about
the
criteria
and
weighing
in
on
whether
or
not
these
feel
like
the
right
criteria
and
really
informing
how
we
think
that
these
criteria
should
be
utilized
by
the
drafting
guidelines.
B
Work
group
in
doing
that
rank
order,
assessment
of
the
phase
one
be
essential
workers,
and
one
of
the
key
things
that
that
I
have
heard
today
is
this
concept
of
intersectionality
of
recognition
that
you
you
know
we
can.
The
the
occupational
exposure
may
intersect
with
the
issues
of
equity,
for
example,
and
we
see
that
certain
we
we're
looking
at
the
data
which
tells
us
that
certain
groups
are
more
likely
to
be
frontline
workers
and
thinking
about
what
that
means.
We
also
want
to.
B
B
We're
also
recognizing
that
some
of
these
some
of
these
groups
represent
important
pathways
of
communication
and
trust
building,
and
we
have
to
think
about.
We
want
to
consider
how
we
can
strengthen
those
pathways
of
communication
and
trust
building,
and
I
think
one
of
the
pieces
that
did
come
up
in
this
conversation
and-
and
we
saw
it
in
the
chat
as
well.
I
was
doing
my
best
to
listen
and
monitor
the
chat
and
try
to
gather
all
the
themes
at
the
same
time.
B
But
this
question
as
to
whether
or
not
the
allocation
strategy
is
based
on
preventing
disease
right,
which
is
way
when
we're
looking
at
what
the
fda
will
decide
on
in
a
proven
use
of
the
vaccine,
and
I
think
this
is
what
the
the
the
teams
at
cdph
as
well
have
been
considering
is
looking
at
the
data
right,
because
you
know
that
that
first
value
that
we're
anchoring
in
is
this
value
of
safety.
So
what
does
the
data
tell
us
about
what
this
vaccine
really?
B
You
know
what
the
evidence
tells
us
as
to
whether
or
not
it's
preventing
severe
in
severe
disease,
which
is
looks
like
the
evidence
that
we
have
right
now
versus
this
other
question
that
you
know
a
reasonable
person
might
think
that
the
vaccine
might
also
in
might
also
prevent
transmission
right
and
and
and
what
does
that
mean,
and-
and
it
sounds
like
from
dr
schechter
right
now-
we
are
looking
looking
at
the
evidence
and
going
with
an
evidence-based
focus
around
prevention
of
severe
disease,
and
so
we
want
to
consider
that
into
how
do
we
think
about
that
into
our
our
rank
order
decision
making?
B
E
Thank
you
and
thank
you
for
for
guiding
me
out
of
out
of
mute
and
thank
you
for
for
the
the
succinct
summary
of
of
of
the
vigorous
conversation
over
the
over
the
over
the
three
hours
we
will.
We
will
take
these
we'll
take
these
criteria,
we'll
take
these
themes
of
intersectionality
and
and
looking
at
these
criteria
and
and
the
data
presented
today
by
dr
chapman
and
additional
data
we
can.
E
We
can
get
to
try
and
see
what
these
occupational
risks
are
and
these
risks
of
exposure
and
and
disease
and
things
that
can
that
can
be
measured
within
these
within
these
four
criteria
and
bring
them
bring
them
to
the
group
to
friday
to
start
to
start
looking
at
the
different
to
start
looking
at
the
different
sectors
and
occupations
and
to
to
bring
them
back,
bring
that
bring
those
conclusions
back
to
you
for
for
ongoing
discussion.
B
And
dr
brooks,
do
you
have
any
additional
considerations
that
you
want
to
share
with
the
committee
about
the
next
steps
from
the
drafting
guidelines
work
group.
AF
Will
meet
is
that
what
you're
in
terms
of
drafting
right
right
so
we'll
meet
we're
going
to
meet
on
friday
and
we're
going
to
take
this
information
that
you
presented
and
then
we're
going
to
integrate
it
into
our
processes,
and
we
we
took
from
you
all
those
four
criteria
and
that
was
very
helpful
and
then
we
worked
with
it
and
we
got
you
know
some
bullet
points
give
it
go
a
little
deeper
now,
basically,
information
shared
today,
we'll
take
it
and
then.
AF
It
into
that
and
then
go
a
little
deeper
and
then,
as
we
do
that
in
terms
of
specifically
which
sectors
which
occupations
I
missed
all
the
description
or
discussion
on
that,
but
which
ones
you
know,
look
like
based
on
what
you
all
are
giving
to
us
should
be
in
the
different
tiers,
we're
going
to
really
chew
on
that
and
then
come
back
to
you
so
we're
it's
been
a
it's
been
a
great
partnership.
AF
N
AF
Chat
is
available,
so
we
have
all
that
information.
My
summary
from
your
last
meeting
was
like
19
pages
or
something
so
we.
AF
Enjoy
getting
all
that
information
we
will
we'll.
You
know
we'll
we're
taking
step
by
step.
B
Thank
you,
dr
brooks,
and
I
want
to
thank
everyone
for
the
robust
discussion
in
this
meeting.
I
want
to
highlight
that
there
there
have
been
a
lot
of
messages
in
the
chat
and
we've
discussed
as
well.
The
theme
of
of
messaging
trusted
messengers,
vaccine
acceptability,
communicating
to
vulnerable
or
hard-to-reach
communities,
and
that
is
something
that
we
are
going
to
discuss
at
our
next
meeting
and
really
thinking
about,
and
that's
a
time
where
we
really
want
to
hear
more
from
you
as
to
some
of
those
thoughtful
strategies.
B
It's
it
feels
like
we
have
so
much
to
do
as
part
of
this
part
of
this
process
and
part
of
this
meeting
process,
but
I'm
really
grateful
that
we've
been
able
to
move
kind
of
deliberately
through
this
process
with
the
decisions
that
we
need
to
make.
B
First,
that
are
that
predicate
some
of
the
work
that's
going
to
come
next,
that
we
as
a
as
a
group,
have
been
able
to
move
through
that
in
a
really
thoughtful
way,
and
so
in
today's
meeting
we
were
able
to
inform
and
give
robust
consideration
about
the
criteria
that
the
drafting
guidelines
work
group
is
going
to
take
and
in
the
next
meeting,
we're
really
going
to
be
able
to
dive
in
a
little
bit
more
into
our
strategies
for
communication
messaging
and
how
we
are
talking,
how
we
are
reaching
communities
to
address
these
issues.
B
Some
of
the
issues
around
vaccine
hesitancy
and
making
sure
that
our
public
is
informed,
making
sure
that
folks
are
getting
the
information
about
how
they
can
protect
themselves.
And
what
are
you
know,
the
the
decisions,
the
information
that
each
individual
or
community
needs
to
be
able
to
make
an
informed
decision
about
the
vaccine,
and
so
with
that,
I
want
to
turn
it
back
over
to
bobby
with
any
final
housekeeping
issues.
A
Well
housekeeping
my
favorite
thing
to
do.
Thank
you,
dr
berkers.
I
love
it
so,
first
of
all,
and
and
perhaps
most
importantly
here
are
the
meetings
that
we
are
planning
for
january
and
february-
mark
your
calendars,
but
either
later
tonight
or
tomorrow
morning,
you'll
get
outlook
calendar
appointments
to
hold
these
times.
I
want
to
thank
our
asl
interpreters,
katie
and
vicky.
Three
hours
is
a
long
time
to
do
what
they've
done
and
it's
always
a
piece
of
artwork
to
watch
them.
A
So
thank
you
all
very
much
we're
going
to
do
a
short
evaluation
for
the
members
about
how
the
meetings
are
going
and
we'll
do
a
quick,
four
or
five
question
survey.
Monkey
over
the
next
few
days
so
would
really
appreciate
your
candid
feedback
on
what
we
can
do
to
improve
the
meetings
and
we'll
look
forward
to
your
feedback
on
that
for
members
of
the
public
who
have
been
listening
on
the
telephone
or
through
the
live
stream.
A
B
And
I
just
in
closing,
I
want
to
note
that
there
are.
There
were
some
questions
that
folks
put
in
the
chat
that
we
weren't
immediately
able
to
get
to
during
the
meeting,
but
we
will
take
that
back.
Take
that
back
to
our
teams
and
make
sure
that
we
get
responses
for
you.
So
with
that,
I
want
to
thank
everyone
for
your
time
and
for
your
rich
and
robust
engagement.